1 |
**comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter. |
- |
- |
- |
- |
086 [1] 86 💬 |
2 |
0.9% normal saline (control) |
- |
- |
- |
- |
299 [1] 299 💬 |
3 |
0.9% sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [4] 6 , 14, 51, 53 💬 |
4 |
0.9% sodium chloride (normal saline) |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [1] 6 💬 |
5 |
0.9% sodium chloride injection |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
168 [1] 168 💬 |
6 |
0.9% w/v isotonic sodium chloride solution |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
050 [1] 50 💬 |
7 |
0.9% w/v sodium chloride solution |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
299 [1] 299 💬 |
8 |
100 mg elx/50 mg tez/75 mg iva fixed dose combination |
- |
- |
- |
- |
299 [1] 299 💬 |
9 |
13 valent conjugated pneumococcal vaccine |
- |
- |
- |
- |
265 [1] 265 💬 |
10 |
13-valent pneumococcal conjugate vaccine |
- |
- |
- |
- |
046 [2] 46, 53 💬 |
11 |
13-valent pneumococcal conjugate vaccine (13-pcv) |
- |
- |
- |
- |
013 [1] 13 💬 |
12 |
13-valent pneumococcal conjugated vaccine (pcv13) |
- |
- |
- |
- |
096 [1] 96 💬 |
13 |
15 o water |
Water |
[1] D00001 D00001 💬 |
- |
- |
019 [1] 19 💬 |
14 |
15-o labeled water |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
15 |
150 mg double-blinded secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
16 |
150 mg open-label secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
17 |
20mg/0.5ml glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
18 |
3-hydroxy-2-methyl-4h-pyrane-4-one iron (iii) complex (3:1), ferric (3-hydroxy-2-methyl-4-pyrone), tris-maltol-iron (iii), tri=maltol-iron (iii) |
Tromethamine |
[1] D00396 D00396 💬 |
- |
- |
096 [2] 96, 97 💬 |
19 |
300 mg double-blinded secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
20 |
40 mg glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 [2] 2 , 13 💬 |
21 |
40 mg glatiramer acetato |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
22 |
5 asa, enemas, suppositories, corticosteroids |
- |
- |
- |
- |
097 [1] 97 💬 |
23 |
5% glucose water solution |
Dextrose, unspecified form |
[1] D00001 D00001 💬 |
- |
- |
002 [1] 2 💬 |
24 |
5% lidocaine/5 mg/ml 0.02% estradiol compound cream |
Estradiol |
[11] D00105 D00105, D00358 D00358, D01413 D01413, D01617 D01617, D01953 D01953, D02086 D02086, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D08127 D08127 💬 |
ESR1 [7] ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway |
226 [1] 226 💬 |
25 |
5-probe cocktail |
- |
- |
- |
- |
254 [1] 254 💬 |
26 |
50 mg elx/25 mg tez/37.5 mg iva fixed dose combination |
- |
- |
- |
- |
299 [1] 299 💬 |
27 |
5000 iu of cholecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
299 [1] 299 💬 |
28 |
7-valent pneumococcal conjugate vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
29 |
90 mg hydrocortisone acetate suppository with sephure suppository applicator |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
30 |
A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine |
Clarithromycin |
[3] D00276 D00276, D00278 D00278, D00424 D00424 💬 |
- |
- |
096 [1] 96 💬 |
31 |
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (cbus) |
- |
- |
- |
- |
060 [1] 60 💬 |
32 |
A natural remedy for rheumatoid arthritis vs. common drugs |
- |
- |
- |
- |
046 [1] 46 💬 |
33 |
A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
34 |
Aav9-cag-coh-sgsh |
- |
- |
- |
- |
019 [1] 19 💬 |
35 |
Aavrh.10cuhcln2 vector 2.85x10^11 genome copies |
- |
- |
- |
- |
019 [1] 19 💬 |
36 |
Aavrh.10cuhcln2 vector 9.0x10^11 genome copies |
- |
- |
- |
- |
019 [1] 19 💬 |
37 |
Ace-031 (extension of cohort 1 from core study, a031-03) |
- |
- |
- |
- |
113 [1] 113 💬 |
38 |
Ace-031 (extension of cohort 2 from core study, a031-03) |
- |
- |
- |
- |
113 [1] 113 💬 |
39 |
Ace-031 (extension of cohort 3 from core study, a031-03) |
- |
- |
- |
- |
113 [1] 113 💬 |
40 |
Acei/arb and corticosteroids |
- |
- |
- |
- |
066 [1] 66 💬 |
41 |
Acomplia 20 mg film-coated tablets |
- |
- |
- |
- |
193 [1] 193 💬 |
42 |
Active comparator |
- |
- |
- |
- |
006 [2] 6 , 46 💬 |
43 |
Active comparator receiving extavia® |
- |
- |
- |
- |
013 [1] 13 💬 |
44 |
Active control |
- |
- |
- |
- |
013 [1] 13 💬 |
45 |
Actonel 5mg film coated tablets |
- |
- |
- |
- |
274 [1] 274 💬 |
46 |
Actonel once a week 35 mg film-coated tablets |
- |
- |
- |
- |
274 [1] 274 💬 |
47 |
Actonel once a week 5mg film coated tablets |
- |
- |
- |
- |
113 [1] 113 💬 |
48 |
Actonel/optinate 5mg film-coated tablets |
- |
- |
- |
- |
274 [1] 274 💬 |
49 |
Ada umbilical cord blood cells |
- |
- |
- |
- |
065 [1] 65 💬 |
50 |
Adcirca 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
51 |
Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
086 [1] 86 💬 |
52 |
Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
53 |
Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
54 |
Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
55 |
Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
56 |
Adempas 0.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
57 |
Adempas 1 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
58 |
Adempas 1.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
59 |
Adempas 2 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
60 |
Adempas 2.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
61 |
Adempas® 0.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
62 |
Adempas® 1.0 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
63 |
Adempas® 1.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
64 |
Adempas® 2.0 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
65 |
Adempas® 2.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
66 |
Adempas¿ 0.5 mg compressa rivestita con film |
- |
- |
- |
- |
086 [1] 86 💬 |
67 |
Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene |
- |
- |
- |
- |
113 [1] 113 💬 |
68 |
Adeno-associated viral vector serotype 9 containing the human n-acetyl-alpha-glucosaminidase gene |
- |
- |
- |
- |
019 [1] 19 💬 |
69 |
Adipose-cord mesenchymal stromal cells (a-mscs) |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
097 [1] 97 💬 |
70 |
Adjuvant without active component |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
71 |
Adrenal cortical hormone |
- |
- |
- |
- |
224 [1] 224 💬 |
72 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
046 [1] 46 💬 |
73 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
046 [1] 46 💬 |
74 |
Alkalinized lidocaine-heparin |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
75 |
Allogeneic human umbilical cord tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
76 |
Allogeneic mesenchymal stromal cells derived from the umbilical cord |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
049 [1] 49 💬 |
77 |
Ambrisentan 5 mg film-coated tablets |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
78 |
Ambrisentan 5mg film-coated tablets [marketed product] |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
79 |
Amiodarone |
Amiodarone |
[2] D00636 D00636, D02910 D02910 💬 |
ADRA1A [16] ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [31] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 [2] 28, 127 💬 |
80 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
[6] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 [3] OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
81 |
Ammonium chloride |
Ammonium chloride |
[1] D01139 D01139 💬 |
- |
- |
096 [1] 96 💬 |
82 |
Androgel 10 grams of gel containing 100 mg of testosterone |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 [1] 13 💬 |
83 |
Angiotensin-converting enzyme (ace) inhibitor |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
224 [1] 224 💬 |
84 |
Angiotensin-converting enzyme inhibitor(acei) |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
224 [1] 224 💬 |
85 |
Anti human granulocyte-macrophage colo |
- |
- |
- |
- |
046 [1] 46 💬 |
86 |
Anti human granulocyte-macrophage colony-stimulating factor (gm-csf) monoclonal |
- |
- |
- |
- |
046 [1] 46 💬 |
87 |
Anti human granulocyte-macrophage colony-stimulating factor (gm-csf) monoclonal antibody |
- |
- |
- |
- |
046 [1] 46 💬 |
88 |
Anti tnf humanized antibody fab fragment-peg conjugate |
- |
- |
- |
- |
096 [1] 96 💬 |
89 |
Anti-tnf humanized antibody fab fragment - peg conjugate |
- |
- |
- |
- |
046 [1] 46 💬 |
90 |
Anti-tnf humanized antibody fab' fragment - peg conjugate |
- |
- |
- |
- |
046 [1] 46 💬 |
91 |
Anti-tnfa continued perioperatively |
- |
- |
- |
- |
046 [1] 46 💬 |
92 |
Antibiotic cocktail |
- |
- |
- |
- |
097 [1] 97 💬 |
93 |
Antimicrobial therapy: co-trimoxazole or doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
085 [1] 85 💬 |
94 |
Antioxidant cocktail |
- |
- |
- |
- |
299 [1] 299 💬 |
95 |
Arcoxia 90 mg comprimidos recubiertos con película |
- |
- |
- |
- |
271 [1] 271 💬 |
96 |
Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis) |
Atazanavir |
[3] D00427 D00427, D01276 D01276, D07471 D07471 💬 |
- |
- |
265 [1] 265 💬 |
97 |
Atg conditioning regimen |
- |
- |
- |
- |
060 [1] 60 💬 |
98 |
Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse |
- |
- |
- |
- |
013 [1] 13 💬 |
99 |
Autologous (self) mononuclear cells derived from umbilical cord blood |
- |
- |
- |
- |
211 [1] 211 💬 |
100 |
Autologous cd34+ cells transduced with a lentiviral vector containing the human sgsh gene |
- |
- |
- |
- |
019 [1] 19 💬 |
101 |
Autologous cd34+ cells transduced with the lentiviral vector containing the human wiskott aldrich sy |
- |
- |
- |
- |
065 [1] 65 💬 |
102 |
Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with lentiviral vector that encodes for the human wiskott aldrich syndrome (was) cdna sequence |
- |
- |
- |
- |
065 [1] 65 💬 |
103 |
Autologous human placental cord blood mononuclear cells |
- |
- |
- |
- |
211 [1] 211 💬 |
104 |
Autologous umbilical cord blood |
- |
- |
- |
- |
211 [2] 211, 294 💬 |
105 |
Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al |
- |
- |
- |
- |
006 [1] 6 💬 |
106 |
Avonex/betaseron/copaxone/rebif |
- |
- |
- |
- |
013 [1] 13 💬 |
107 |
Azd4017 and prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
108 |
Azilect 1 mg comprimidos |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
109 |
Azithromycin + n-acetylcystein + inhaled corticosteroid |
Azithromycin |
[3] D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
228 [1] 228 💬 |
110 |
Azithromycin 500 mg film-coated tablet |
Azithromycin |
[3] D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
299 [1] 299 💬 |
111 |
B-peptide-crm197 conjugate |
- |
- |
- |
- |
011 [1] 11 💬 |
112 |
Balsalazide |
Balsalazide |
[2] D02715 D02715, D07488 D07488 💬 |
- |
- |
097 [1] 97 💬 |
113 |
Balsalazide disodium |
Balsalazide |
[2] D02715 D02715, D07488 D07488 💬 |
- |
- |
097 [1] 97 💬 |
114 |
Bay 63-2521 coated tablets 0.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
115 |
Bay 63-2521 coated tablets 1 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
116 |
Bay 63-2521 coated tablets 1.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
117 |
Bay 63-2521 coated tablets 2 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
118 |
Bay 63-2521 coated tablets 2.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
119 |
Bay 63-2521 ir coated tablet 1.0 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
120 |
Bay 63-2521 ir coated tablet 1.5 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
121 |
Bay 63-2521 ir coated tablet 2.0 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
122 |
Bay 63-2521 ir coated tablet 2.5 mg |
- |
- |
- |
- |
088 [1] 88 💬 |
123 |
Befizal l.p. 400 mg, comprimé enrobé à libération prolongée |
- |
- |
- |
- |
094 [1] 94 💬 |
124 |
Behavioral: adherence counseling |
- |
- |
- |
- |
013 [1] 13 💬 |
125 |
Behavioral: assessment of cognition |
- |
- |
- |
- |
006 [1] 6 💬 |
126 |
Behavioral: assessment of impact of ms on cognition |
- |
- |
- |
- |
013 [1] 13 💬 |
127 |
Behavioral: assessment of severity of icd (impulse control disorders) |
- |
- |
- |
- |
006 [1] 6 💬 |
128 |
Behavioral: attention control |
- |
- |
- |
- |
006 [1] 6 💬 |
129 |
Behavioral: co-op treatment protocol |
- |
- |
- |
- |
006 [1] 6 💬 |
130 |
Behavioral: cognitive and behavioral experimental tasks |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
131 |
Behavioral: collaborative care (cc) |
- |
- |
- |
- |
013 [1] 13 💬 |
132 |
Behavioral: colonic lavage |
- |
- |
- |
- |
291 [1] 291 💬 |
133 |
Behavioral: combined balance and brisk walking training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
134 |
Behavioral: conservative measures for orthostatic hypotension |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
135 |
Behavioral: conservative treatment |
- |
- |
- |
- |
291 [1] 291 💬 |
136 |
Behavioral: diet and water adjustment |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
137 |
Behavioral: diet counseling |
- |
- |
- |
- |
096 [1] 96 💬 |
138 |
Behavioral: dietary counseling |
- |
- |
- |
- |
046 [1] 46 💬 |
139 |
Behavioral: healthy age-matched controls |
- |
- |
- |
- |
006 [1] 6 💬 |
140 |
Behavioral: increased dietary intake of salmon or cod |
Salmon, unspecified |
- |
- |
- |
097 [1] 97 💬 |
141 |
Behavioral: low-impact exercise control |
- |
- |
- |
- |
006 [1] 6 💬 |
142 |
Behavioral: montreal cognitive assessment (moca) |
- |
- |
- |
- |
017 [1] 17 💬 |
143 |
Behavioral: protein and calorie controlled diet |
- |
- |
- |
- |
251 [1] 251 💬 |
144 |
Behavioral: respiratory and exercise therapy with supplemental oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
088 [1] 88 💬 |
145 |
Behavioral: telephone-based cognitive behavioral therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
146 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
147 |
Behavioral: water tracking |
Water |
[1] D00001 D00001 💬 |
- |
- |
013 [1] 13 💬 |
148 |
Benlysta - 120 mg - polvere per concentrato per soluzione per infusione - uso endovenoso - flaconcino (vetro) 120 mg 1 flaconcino |
- |
- |
- |
- |
053 [1] 53 💬 |
149 |
Benlysta 400 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
043 [2] 43, 49 💬 |
150 |
Benlysta 400 mg powder for concentrate for solution for infusions |
- |
- |
- |
- |
049 [1] 49 💬 |
151 |
Benlysta 400mg polvere per concentrato per soluzione per infusione |
- |
- |
- |
- |
043 [1] 43 💬 |
152 |
Berberine |
Berberine |
[1] D00092 D00092 💬 |
- |
- |
097 [1] 97 💬 |
153 |
Berberine chloride |
Berberine |
[1] D00092 D00092 💬 |
- |
- |
097 [1] 97 💬 |
154 |
Beta-adrenergic cocktail |
- |
- |
- |
- |
299 [1] 299 💬 |
155 |
Biib033 (anti-lingo) - ev substance code sub118957 |
- |
- |
- |
- |
013 [1] 13 💬 |
156 |
Bio-enhanced curcumin soft gelatin capsule |
Curcumin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
097 [1] 97 💬 |
157 |
Biological: umbilical cord based allogenic mesenchymal stem cell |
- |
- |
- |
- |
113 [1] 113 💬 |
158 |
Bladder instillation with heparin/ lidocaine |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
159 |
Blokium 50 mg comprimidos |
- |
- |
- |
- |
167 [1] 167 💬 |
160 |
Blood coagulation factor viii and vwf, human |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
161 |
Blood coagulation factor xiii |
Factor XIII (human) |
- |
- |
- |
051 [1] 51 💬 |
162 |
Blood collection |
- |
- |
- |
- |
271 [1] 271 💬 |
163 |
Blood sample collection |
- |
- |
- |
- |
085 [1] 85 💬 |
164 |
Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) |
Digoxin |
[13] D00298 D00298, D00330 D00330, D00455 D00455, D00529 D00529, D00550 D00550, D00696 D00696, D01207 D01207, D01475 D01475, D02290 D02290, D05028 D05028, D05259 D05259, D05261 D05261, D08229 D08229 💬 |
ATP1A1 [25] ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 |
Adrenergic signaling in cardiomyocytes [49] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
165 |
Bone marrow concentrate |
- |
- |
- |
- |
070 [1] 70 💬 |
166 |
Boots high strength garlic odour controlled |
Garlic |
- |
- |
- |
299 [1] 299 💬 |
167 |
Botulinum toxin a - haemagglutinin complex |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
013 [1] 13 💬 |
168 |
Bovine type i collagen |
Bovine type I collagen |
- |
- |
- |
051 [1] 51 💬 |
169 |
Bpr277 ointment (controlled application) |
- |
- |
- |
- |
160 [1] 160 💬 |
170 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
[14] D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
171 |
Busilvex - 6 mg/ml - concentrato per soluzione per infusione - uso endovenoso - flaconcino - 10 ml 8 flaconcini |
- |
- |
- |
- |
019 [2] 19, 65 💬 |
172 |
Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen) |
Antithymocyte immunoglobulin (rabbit) |
[5] D00248 D00248, D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
326 [1] 326 💬 |
173 |
C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
276 [1] 276 💬 |
174 |
C1 inhibitor concentrate |
Human C1-esterase inhibitor |
- |
- |
- |
065 [1] 65 💬 |
175 |
Cabozantinib |
Cabozantinib |
[1] D10062 D10062 💬 |
AXL [3] AXL, KDR, MET 💬 |
Adherens junction [24] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway |
034 [1] 34 💬 |
176 |
Calcium and cholecalciferol |
Calcium |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 [1] 46 💬 |
177 |
Calcium and vitamin d combination |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
178 |
Canakinumab (company code: acz885d) |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
106 [1] 106 💬 |
179 |
Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
180 |
Carbidopa, levodopa, entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
181 |
Carbidopa/l-dopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
182 |
Carbidopa/levodopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
183 |
Carvedilol |
Carvedilol |
[2] D00255 D00255, D03415 D03415 💬 |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway [12] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 57, 86, 113, 210 💬 |
184 |
Cbdv compound |
Cannabidivarin |
- |
- |
- |
193 [1] 193 💬 |
185 |
Cellcept 500 mg comprimidos recubiertos |
- |
- |
- |
- |
035 [1] 35 💬 |
186 |
Cellcept 500 mg film-coated tablets |
- |
- |
- |
- |
011 [1] 11 💬 |
187 |
Cellcept®500 mg comprimidos |
- |
- |
- |
- |
035 [1] 35 💬 |
188 |
Cellule cd34+ autologhe trasdotte con idua lv codificante per il cdna dell'alfa-l-iduronidasi |
- |
- |
- |
- |
019 [1] 19 💬 |
189 |
Cfz533 active - cohort 1 |
- |
- |
- |
- |
053 [1] 53 💬 |
190 |
Cfz533 active - cohort 2 |
- |
- |
- |
- |
053 [1] 53 💬 |
191 |
Cfz533 active - cohort 3 |
- |
- |
- |
- |
053 [1] 53 💬 |
192 |
Cfz533 active -cohort 3 |
- |
- |
- |
- |
053 [1] 53 💬 |
193 |
Chemical conjugate of recombinant human growth hormone (rhgh) and human immunoglobulin g4 fragment (hmc001) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
194 |
Chicken type ii collagen |
Chicken |
- |
- |
- |
046 [1] 46 💬 |
195 |
Chinese herbal concoction twice a day for 6 months |
- |
- |
- |
- |
060 [1] 60 💬 |
196 |
Chlorpromazine |
Chlorpromazine |
[4] D00270 D00270, D00789 D00789, D03274 D03274, D04034 D04034 💬 |
ADRA2A [13] ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
254 [1] 254 💬 |
197 |
Chlorpromazine hydrochloride |
Chlorpromazine |
[4] D00270 D00270, D00789 D00789, D03274 D03274, D04034 D04034 💬 |
ADRA2A [13] ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
254 [1] 254 💬 |
198 |
Cholecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [9] 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
199 |
Cholecalciferol (vitamin d3) |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [2] 13, 299 💬 |
200 |
Cholecalciferol (vitamind3) |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
299 [1] 299 💬 |
201 |
Cholecalciferol 10,000 iu |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
202 |
Cholecalciferol 400 iu |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
203 |
Cholecalciferol and c. xanthorrhiza |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
049 [1] 49 💬 |
204 |
Cholecalciferol concentrate |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
205 |
Cholecalciferol concentrate (water-dispersible form) |
Cholecalciferol |
[2] D00001 D00001, D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
206 |
Cholecalciferol, vitamin d3 |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [1] 13 💬 |
207 |
Chronic corticosteroid therapy |
- |
- |
- |
- |
113 [1] 113 💬 |
208 |
Cialis - 20 mg 2 compresse rivestite con film in blister uso orale |
- |
- |
- |
- |
075 [1] 75 💬 |
209 |
Cialis 10 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
210 |
Cialis 2.5 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
211 |
Cialis 20 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
212 |
Cialis 20 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
213 |
Cialis 5 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
214 |
Circadin 2 mg comprimidos de liberación prolongada |
- |
- |
- |
- |
090 [1] 90 💬 |
215 |
Claritromycin 500mg film coated tablets |
- |
- |
- |
- |
299 [1] 299 💬 |
216 |
Clenbuterol |
Clenbuterol |
[1] D07713 D07713 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
001 [4] 1 , 2 , 6 , 256 💬 |
217 |
Clenbuterol hcl |
Clenbuterol |
[1] D07713 D07713 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
218 |
Clenbuterol hydrochloride |
Clenbuterol |
[1] D07713 D07713 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
219 |
Clobetasol propionate |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 162 💬 |
220 |
Clobetasol propionate + methotrexate |
Clobetasol |
[4] D00142 D00142, D01272 D01272, D02115 D02115, D07715 D07715 💬 |
DHFR [3] DHFR, DHFR2, NR3C1 💬 |
Antifolate resistance [6] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate |
162 [1] 162 💬 |
221 |
Clobetasol propionate alone |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
222 |
Clobetasol propionate cream treatment |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
223 |
Co |
- |
- |
- |
- |
006 [5] 6 , 13, 53, 70, 85 💬 |
224 |
Co-14 |
- |
- |
- |
- |
013 [1] 13 💬 |
225 |
Co-medication: synthetic dmards |
- |
- |
- |
- |
046 [1] 46 💬 |
226 |
Co-trimoxazole |
- |
- |
- |
- |
085 [1] 85 💬 |
227 |
Coa |
- |
- |
- |
- |
120 [1] 120 💬 |
228 |
Coagulación factor viii |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
229 |
Coagulation factor viii |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
230 |
Coagulation factor xiii |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
231 |
Coamoxiclav |
- |
- |
- |
- |
097 [1] 97 💬 |
232 |
Cobalt |
Cobalt |
- |
- |
- |
046 [1] 46 💬 |
233 |
Cobamamide |
Cobamamide |
[1] D00042 D00042 💬 |
- |
- |
299 [1] 299 💬 |
234 |
Cobiprostone |
Cobiprostone |
[1] D08893 D08893 💬 |
- |
- |
046 [1] 46 💬 |
235 |
Cobitolimod |
Cobitolimod |
- |
- |
- |
097 [1] 97 💬 |
236 |
Cocoa |
Cocoa |
- |
- |
- |
006 [1] 6 💬 |
237 |
Coconut |
Coconut |
- |
- |
- |
013 [2] 13, 53 💬 |
238 |
Coconut oil |
Coconut |
[1] D05326 D05326 💬 |
- |
- |
013 [1] 13 💬 |
239 |
Coconut oil and epigallocatechin gallate |
Coconut |
[1] D05326 D05326 💬 |
- |
- |
013 [1] 13 💬 |
240 |
Cod |
- |
- |
- |
- |
046 [1] 46 💬 |
241 |
Cod liver oil |
Cod liver oil |
[1] D03578 D03578 💬 |
- |
- |
046 [1] 46 💬 |
242 |
Coenzym q10 nanodispersion |
- |
- |
- |
- |
005 [1] 5 💬 |
243 |
Coenzym q10, ubiquinon, ubichinon |
- |
- |
- |
- |
005 [1] 5 💬 |
244 |
Coenzyme q |
- |
- |
- |
- |
013 [1] 13 💬 |
245 |
Coenzyme q-10 |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
086 [1] 86 💬 |
246 |
Coenzyme q-10 in normal control subjects |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
086 [1] 86 💬 |
247 |
Coenzyme q-10 in pulmonary hypertension subjects |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
086 [1] 86 💬 |
248 |
Coenzyme q10 |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
002 [12] 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
249 |
Coenzyme q10 and lisinopril |
Lisinopril |
[3] D00362 D00362, D01065 D01065, D08131 D08131 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
113 [1] 113 💬 |
250 |
Coenzyme q10 nanodispersion (nanoquinone) |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
006 [1] 6 💬 |
251 |
Coenzyme q10 with vitamin e |
Ubidecarenone |
[2] D01065 D01065, D02331 D02331 💬 |
- |
- |
006 [1] 6 💬 |
252 |
Coenzymeq10 |
- |
- |
- |
- |
021 [1] 21 💬 |
253 |
Cofactor |
- |
- |
- |
- |
006 [3] 6 , 265, 288 💬 |
254 |
Cofactor supplementation (thiamine, riboflavin, l-carnitine) |
Levocarnitine |
[7] D00050 D00050, D01622 D01622, D01913 D01913, D02030 D02030, D02176 D02176, D04713 D04713, D08580 D08580 💬 |
- |
- |
265 [1] 265 💬 |
255 |
Coffee |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
256 |
Coffee coal |
- |
- |
- |
- |
097 [1] 97 💬 |
257 |
Cogane |
- |
- |
- |
- |
006 [1] 6 💬 |
258 |
Cogane™ (pym50028) |
- |
- |
- |
- |
006 [1] 6 💬 |
259 |
Cohort 1 0.225g |
- |
- |
- |
- |
240 [1] 240 💬 |
260 |
Cohort 1: 1.0 x 10^8 polytregs |
- |
- |
- |
- |
035 [1] 35 💬 |
261 |
Cohort 1: hatg, csa, epag day 14 to month 6 |
Antilymphocyte immunoglobulin (horse) |
[1] D08808 D08808 💬 |
- |
- |
060 [1] 60 💬 |
262 |
Cohort 1:nilotinib oral capsules (150mg or 300mg) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
263 |
Cohort 2 0.75g |
- |
- |
- |
- |
240 [1] 240 💬 |
264 |
Cohort 2: 2.5x10^8 polytregs |
- |
- |
- |
- |
035 [1] 35 💬 |
265 |
Cohort 2: hatg, csa, epag day 14 to month 3 |
Antilymphocyte immunoglobulin (horse) |
[1] D08808 D08808 💬 |
- |
- |
060 [1] 60 💬 |
266 |
Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
267 |
Cohort 3 2.25 g |
- |
- |
- |
- |
240 [1] 240 💬 |
268 |
Cohort 3: hatg, csa (dose reduced), epag day 1 to month 6 |
Antilymphocyte immunoglobulin (horse) |
[1] D08808 D08808 💬 |
- |
- |
060 [1] 60 💬 |
269 |
Col7a1-sin retroviral vector engineered autologous tissue-engineered skin |
- |
- |
- |
- |
036 [1] 36 💬 |
270 |
Colal pred |
- |
- |
- |
- |
097 [1] 97 💬 |
271 |
Colal-pred |
- |
- |
- |
- |
097 [1] 97 💬 |
272 |
Colal-pred® |
- |
- |
- |
- |
097 [1] 97 💬 |
273 |
Colazide |
- |
- |
- |
- |
097 [1] 97 💬 |
274 |
Colchicina |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 [1] 2 💬 |
275 |
Colchicina lirca - 1 mg compresse 60 compresse |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 [1] 2 💬 |
276 |
Colchicine |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 [7] 2 , 42, 46, 56, 93, 210, 266 💬 |
277 |
Colchicine 1 mg oral tablet |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 [1] 2 💬 |
278 |
Colchicine sprinkle capsules |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
279 |
Colecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [4] 13, 46, 96, 228 💬 |
280 |
Colecalciferol concentrate (oily form) |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [1] 13 💬 |
281 |
Colecalciferol d3 (vigantol oil) |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
282 |
Colesevelam |
Colesevelam |
[2] D03582 D03582, D07743 D07743 💬 |
- |
- |
096 [2] 96, 260 💬 |
283 |
Colestipol |
Colestipol |
[2] D02113 D02113, D07771 D07771 💬 |
- |
- |
254 [1] 254 💬 |
284 |
Colestyramine |
Cholestyramine |
- |
- |
- |
254 [1] 254 💬 |
285 |
Colimicina |
- |
- |
- |
- |
299 [1] 299 💬 |
286 |
Colimicina - 1000000 u/4 ml polvere e solvente per soluzione iniettabile per uso intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ml |
- |
- |
- |
- |
299 [1] 299 💬 |
287 |
Colimycine |
- |
- |
- |
- |
299 [1] 299 💬 |
288 |
Colimycine inhalation |
- |
- |
- |
- |
299 [1] 299 💬 |
289 |
Colimycine injectable |
- |
- |
- |
- |
299 [1] 299 💬 |
290 |
Colistimetato sodico |
- |
- |
- |
- |
299 [1] 299 💬 |
291 |
Colistimethat-natrium |
- |
- |
- |
- |
299 [1] 299 💬 |
292 |
Colistimethate |
Colistimethate |
[1] D02049 D02049 💬 |
- |
- |
299 [1] 299 💬 |
293 |
Colistimethate 75 mg inhaled two times daily |
Colistimethate |
[1] D02049 D02049 💬 |
- |
- |
299 [1] 299 💬 |
294 |
Colistimethate sodium |
Colistimethate |
[1] D02049 D02049 💬 |
- |
- |
299 [1] 299 💬 |
295 |
Colistimethate sodium (a component) |
Colistimethate |
[1] D02049 D02049 💬 |
- |
- |
299 [1] 299 💬 |
296 |
Colistimethate sodium (ban, usan), colistimethatum natricum, colistin sodium methanesulfonate |
Colistimethate |
[3] D02049 D02049, D02138 D02138, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
297 |
Colistimethate sodium (promixin) |
Colistimethate |
[1] D02049 D02049 💬 |
- |
- |
299 [1] 299 💬 |
298 |
Colistin |
Colistin |
[2] D02138 D02138, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
299 |
Colistin cf |
Colistin |
[2] D02138 D02138, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
300 |
Colistin forest - trockenstechampullen mit lösungsmittel |
Colistin |
[2] D02138 D02138, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
301 |
Colistin mesilate sodium |
Colistin |
[2] D02138 D02138, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
302 |
Colistineb |
- |
- |
- |
- |
299 [1] 299 💬 |
303 |
Colistineb 2mui |
- |
- |
- |
- |
299 [1] 299 💬 |
304 |
Collagenase |
Collagenase clostridium histolyticum |
[1] D09596 D09596 💬 |
- |
- |
162 [1] 162 💬 |
305 |
Collect of 10 ml of peripheric blood for dna extraction |
- |
- |
- |
- |
046 [1] 46 💬 |
306 |
Collection of blood and urine |
- |
- |
- |
- |
025 [1] 25 💬 |
307 |
Colobreathe |
- |
- |
- |
- |
299 [1] 299 💬 |
308 |
Colomycin |
- |
- |
- |
- |
299 [1] 299 💬 |
309 |
Colony-purified bacteroides thetaiotaomicron (b.theta) |
- |
- |
- |
- |
096 [1] 96 💬 |
310 |
Coltect |
- |
- |
- |
- |
097 [1] 97 💬 |
311 |
Combination |
- |
- |
- |
- |
046 [1] 46 💬 |
312 |
Combination antiviral therapy |
- |
- |
- |
- |
093 [1] 93 💬 |
313 |
Combination fish oil and borage seed oil |
Fish oil |
- |
- |
- |
046 [1] 46 💬 |
314 |
Combination injection of epo and g-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
006 [1] 6 💬 |
315 |
Combination of a single dose anti-cd20 antibody and bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
061 [1] 61 💬 |
316 |
Combination of fish oil and colesevelam |
Colesevelam |
[2] D03582 D03582, D07743 D07743 💬 |
- |
- |
260 [1] 260 💬 |
317 |
Combination of minocycline and mtx or mtx alone |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
046 [1] 46 💬 |
318 |
Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine |
Azathioprine |
[12] D00238 D00238, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994, D03033 D03033 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
319 |
Combination of thrombopoietin mimetic and cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
320 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
[2] D00088 D00088, D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
321 |
Combination product (natpara) and drug or supplements [disease and drug registry] |
- |
- |
- |
- |
235 [1] 235 💬 |
322 |
Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) |
- |
- |
- |
- |
086 [1] 86 💬 |
323 |
Combination product: active treatment with dual therapy |
- |
- |
- |
- |
002 [1] 2 💬 |
324 |
Combination product: beclomethasone dipropionate in addition to mc-evoo |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
325 |
Combination product: beclomethasone dipropionate in addition to refined oil |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
326 |
Combination product: belimumab |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
327 |
Combination product: goldic serum |
- |
- |
- |
- |
070 [1] 70 💬 |
328 |
Combination product: hyperbaric oxygen therapy- |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
226 [1] 226 💬 |
329 |
Combination product: implantable system for remodulin (treprostinil) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
330 |
Combination product: l-dopa 140 mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
331 |
Combination product: l-dopa 35 mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
332 |
Combination product: l-dopa 70mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
333 |
Combination product: l-dopa 70mg/carbidopa 7mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
334 |
Combination product: mavrilimumab |
Mavrilimumab |
[1] D09930 D09930 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
041 [1] 41 💬 |
335 |
Combination product: methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
336 |
Combination product: nd0612 solution for sc infusion |
- |
- |
- |
- |
006 [1] 6 💬 |
337 |
Combination product: ofatumumab with ai |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
338 |
Combination product: ofatumumab with prf |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
339 |
Combination product: prp combined magnovision |
- |
- |
- |
- |
090 [1] 90 💬 |
340 |
Combination product: transcon pth |
- |
- |
- |
- |
235 [1] 235 💬 |
341 |
Combination product: treprostinil via implanted pump |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
342 |
Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
343 |
Combination steroid |
- |
- |
- |
- |
046 [1] 46 💬 |
344 |
Combination therapy with vigabatrin and prednisolone |
Prednisolone |
[9] D00472 D00472, D00535 D00535, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
ABAT [2] ABAT, NR3C1 💬 |
Alanine, aspartate and glutamate metabolism [8] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
345 |
Combined plasma exchange (pex), rituximab, and corticosteroids |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
085 [1] 85 💬 |
346 |
Combivir |
- |
- |
- |
- |
265 [1] 265 💬 |
347 |
Combivir (zidovudine [azt] / lamivudine [3tc]) |
Lamivudine |
[2] D00353 D00353, D00413 D00413 💬 |
- |
- |
265 [1] 265 💬 |
348 |
Commercial formulation etanercept |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
349 |
Commercial ventavis® (iloprost) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
350 |
Common name: sialic acid |
- |
- |
- |
- |
030 [1] 30 💬 |
351 |
Comparator: carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
352 |
Comparator: diclofenac |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
353 |
Comparator: diclofenac sodium |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
354 |
Comparator: ezetimibe |
Ezetimibe |
[1] D01966 D01966 💬 |
NPC1L1 [1] NPC1L1 💬 |
Fat digestion and absorption [1] Fat digestion and absorption |
079 [2] 79, 260 💬 |
355 |
Comparator: levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
356 |
Comparator: naproxen tablet 500 mg |
Naproxen |
[1] D00118 D00118 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
357 |
Complement c1 esterase inhibitor |
Conestat alfa |
[1] D10845 D10845 💬 |
C1R [3] C1R, C1S, KLKB1 💬 |
Complement and coagulation cascades [6] Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus |
061 [1] 61 💬 |
358 |
Compound 1a |
- |
- |
- |
- |
246 [2] 246, 299 💬 |
359 |
Compound 21 |
- |
- |
- |
- |
085 [1] 85 💬 |
360 |
Compound thrombosis capsule sig: 1.5g/tid |
- |
- |
- |
- |
090 [1] 90 💬 |
361 |
Comtan |
- |
- |
- |
- |
006 [1] 6 💬 |
362 |
Comtan 200* 60 cpr 200 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
363 |
Comtan® |
- |
- |
- |
- |
006 [1] 6 💬 |
364 |
Comtanâ® |
- |
- |
- |
- |
006 [1] 6 💬 |
365 |
Comtess |
- |
- |
- |
- |
006 [1] 6 💬 |
366 |
Comtess® |
- |
- |
- |
- |
006 [1] 6 💬 |
367 |
Concentration unit: mg milligram(s) |
- |
- |
- |
- |
254 [1] 254 💬 |
368 |
Concerta |
- |
- |
- |
- |
203 [1] 203 💬 |
369 |
Conditioned medium (cm) |
- |
- |
- |
- |
090 [1] 90 💬 |
370 |
Confortid |
- |
- |
- |
- |
225 [1] 225 💬 |
371 |
Conivaptan |
Conivaptan |
[2] D01236 D01236, D07748 D07748 💬 |
AVPR1A [2] AVPR1A, AVPR2 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
372 |
Conjugated equine estrogens |
Conjugated estrogens |
[2] D04070 D04070, D05987 D05987 💬 |
- |
- |
049 [1] 49 💬 |
373 |
Conjugated equine estrogens 0.625 mg/d + mpa 5 mg/d/10d |
Conjugated estrogens |
[2] D04070 D04070, D05987 D05987 💬 |
- |
- |
049 [1] 49 💬 |
374 |
Continuation of azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
049 [1] 49 💬 |
375 |
Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis) |
- |
- |
- |
- |
265 [1] 265 💬 |
376 |
Continuous apomorphine infusion |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
377 |
Continuous infusion cefepime |
Cefepime |
[1] D02376 D02376 💬 |
- |
- |
299 [1] 299 💬 |
378 |
Continuous infusion ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
379 |
Continuous infusion meropenem |
Meropenem |
[2] D02222 D02222, D08185 D08185 💬 |
- |
- |
299 [1] 299 💬 |
380 |
Continuous infusion piperacillin tazobactam |
Piperacillin |
[4] D00466 D00466, D00660 D00660, D02251 D02251, D08380 D08380 💬 |
- |
- |
299 [1] 299 💬 |
381 |
Continuous infusion ticarcillin-clavulanate |
Clavulanic acid |
[2] D07711 D07711, D08593 D08593 💬 |
- |
- |
299 [1] 299 💬 |
382 |
Continuous intrajejunal infusion of levodopa-carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
383 |
Continuous oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
090 [1] 90 💬 |
384 |
Continuous release dopamine agonists |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
385 |
Continuous subcutaneous lisuride infusion |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
386 |
Contrast enhanced ultrasound |
- |
- |
- |
- |
096 [1] 96 💬 |
387 |
Control |
- |
- |
- |
- |
006 [4] 6 , 46, 168, 299 💬 |
388 |
Control group |
- |
- |
- |
- |
002 [3] 2 , 46, 70 💬 |
389 |
Control group 0.9% isotonic saline |
- |
- |
- |
- |
299 [1] 299 💬 |
390 |
Control intervention (no dexamethasone) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
391 |
Control multivitamin |
- |
- |
- |
- |
299 [1] 299 💬 |
392 |
Controlled-release levodopa / carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
393 |
Conventional |
- |
- |
- |
- |
063 [1] 63 💬 |
394 |
Conventional dmard combination |
- |
- |
- |
- |
046 [1] 46 💬 |
395 |
Conventional dmards |
- |
- |
- |
- |
046 [1] 46 💬 |
396 |
Conventional drug therapy(expectorant,bronchodilator) |
- |
- |
- |
- |
086 [1] 86 💬 |
397 |
Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) |
Acetate |
[21] D00088 D00088, D00292 D00292, D00472 D00472, D00473 D00473, D00973 D00973, D00975 D00975, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D01998 D01998, D02156 D02156, D02174 D02174, D02591 D02591, D02592 D02592, D03301 D03301, D07749 D07749 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
398 |
Conventional synthetic dmard |
- |
- |
- |
- |
046 [1] 46 💬 |
399 |
Conventional therapy |
- |
- |
- |
- |
067 [2] 67, 222 💬 |
400 |
Coozar |
- |
- |
- |
- |
167 [1] 167 💬 |
401 |
Cop |
- |
- |
- |
- |
013 [1] 13 💬 |
402 |
Cop-1 |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
403 |
Cop-1/copolymer-1 |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
404 |
Copaxone |
- |
- |
- |
- |
013 [1] 13 💬 |
405 |
Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe |
- |
- |
- |
- |
013 [1] 13 💬 |
406 |
Copaxone - 40 mg/ml soluzione iniettabile in siringa preriempita 12 siringhe preriempite da 1 ml con ago |
- |
- |
- |
- |
013 [1] 13 💬 |
407 |
Copaxone 20 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
408 |
Copaxone 20 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
409 |
Copaxone 20 mg/ml solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
410 |
Copaxone 20 mg/ml solución para inyección en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
411 |
Copaxone 20 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
412 |
Copaxone 20 mg/ml, solution for injection, pre-filled syringes |
- |
- |
- |
- |
013 [1] 13 💬 |
413 |
Copaxone 20mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
414 |
Copaxone 40 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
415 |
Copaxone 40 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
416 |
Copaxone subcutaneous injection syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
417 |
Copaxone*sc 28sir 20mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
418 |
Copaxone-teva |
- |
- |
- |
- |
013 [1] 13 💬 |
419 |
Copaxone® |
- |
- |
- |
- |
013 [1] 13 💬 |
420 |
Copegus |
- |
- |
- |
- |
002 [1] 2 💬 |
421 |
Copolymer 1 |
- |
- |
- |
- |
013 [1] 13 💬 |
422 |
Copolymer-1 |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
423 |
Copper |
Copper |
- |
- |
- |
002 [4] 2 , 169, 170, 171 💬 |
424 |
Copper (64cu) chloride |
Chloride ion |
- |
- |
- |
171 [1] 171 💬 |
425 |
Copper histidinate |
Copper |
- |
- |
- |
169 [1] 169 💬 |
426 |
Copper histidine |
Copper |
[1] D00032 D00032 💬 |
- |
- |
169 [2] 169, 170 💬 |
427 |
Coq10 |
- |
- |
- |
- |
005 [3] 5 , 6 , 8 💬 |
428 |
Coqun |
- |
- |
- |
- |
090 [1] 90 💬 |
429 |
Cor-003 |
- |
- |
- |
- |
075 [1] 75 💬 |
430 |
Cord blood |
- |
- |
- |
- |
060 [1] 60 💬 |
431 |
Cord blood therapy |
Umbilical Cord Blood Hematopoietic Stem Cells |
- |
- |
- |
002 [2] 2 , 6 💬 |
432 |
Cord blood transplant |
- |
- |
- |
- |
060 [1] 60 💬 |
433 |
Cord blood units |
- |
- |
- |
- |
060 [1] 60 💬 |
434 |
Cordin |
- |
- |
- |
- |
060 [1] 60 💬 |
435 |
Corn |
Corn |
- |
- |
- |
046 [2] 46, 240 💬 |
436 |
Corn oil capsules |
Corn |
- |
- |
- |
046 [1] 46 💬 |
437 |
Corn starch |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
049 [1] 49 💬 |
438 |
Corn/soy oil |
Corn |
- |
- |
- |
240 [1] 240 💬 |
439 |
Cornstarch |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
090 [2] 90, 257 💬 |
440 |
Cornstarch control |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
090 [1] 90 💬 |
441 |
Cort125134 |
Relacorilant |
[1] D11336 D11336 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
442 |
Cortancyl |
Prednisone acetate |
[1] D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [3] 35, 41, 162 💬 |
443 |
Cortancyl 20 mg |
Prednisone acetate |
[1] D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [2] 35, 162 💬 |
444 |
Cortancyl ® 1 mg |
Prednisone acetate |
[1] D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
445 |
Cortancyl ® 20 mg |
Prednisone acetate |
[1] D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
446 |
Cortancyl ® 5 mg |
Prednisone acetate |
[1] D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
447 |
Cortecosteroid |
- |
- |
- |
- |
096 [1] 96 💬 |
448 |
Cortef |
- |
- |
- |
- |
006 [3] 6 , 81, 83 💬 |
449 |
Cortef (hydrocortisone) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
450 |
Cortef 5 mg |
- |
- |
- |
- |
083 [1] 83 💬 |
451 |
Corticoids+ tocilizumab 8mg/kg/4 weeks |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 [1] 41 💬 |
452 |
Corticosteroid |
- |
- |
- |
- |
013 [10] 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
453 |
Corticosteroid (cs) |
- |
- |
- |
- |
041 [1] 41 💬 |
454 |
Corticosteroid (prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
455 |
Corticosteroid and azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
042 [4] 42, 43, 44, 45 💬 |
456 |
Corticosteroid and non-biological agents. |
- |
- |
- |
- |
046 [1] 46 💬 |
457 |
Corticosteroid or nsaid |
- |
- |
- |
- |
046 [1] 46 💬 |
458 |
Corticosteroid treatment (methylprednisolone or prednisolone) |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
064 [1] 64 💬 |
459 |
Corticosteroids |
- |
- |
- |
- |
041 [10] 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬 |
460 |
Corticosteroids & tancart19/20 |
- |
- |
- |
- |
013 [1] 13 💬 |
461 |
Corticosteroids (aprednislon) |
- |
- |
- |
- |
063 [1] 63 💬 |
462 |
Corticosteroids (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
463 |
Corticosteroids for systemic use |
- |
- |
- |
- |
041 [1] 41 💬 |
464 |
Corticosteroids only |
- |
- |
- |
- |
097 [1] 97 💬 |
465 |
Corticosteroids'therapy |
- |
- |
- |
- |
035 [1] 35 💬 |
466 |
Corticotherapy |
- |
- |
- |
- |
066 [1] 66 💬 |
467 |
Corticotrophin |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
046 [1] 46 💬 |
468 |
Corticotrophin 80 units |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
046 [1] 46 💬 |
469 |
Corticotropin |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [7] 2 , 13, 46, 75, 78, 84, 222 💬 |
470 |
Corticotropin-releasing hormone |
Corticorelin |
[2] D00146 D00146, D03905 D03905 💬 |
CRHR1 [3] CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
471 |
Cortimentmmx 9 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
472 |
Cortisol |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
473 |
Cortison |
- |
- |
- |
- |
081 [1] 81 💬 |
474 |
Cortisone |
Cortisone |
[1] D07749 D07749 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
475 |
Cortisone acetate |
Acetate |
[2] D00973 D00973, D07749 D07749 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
476 |
Cosentyx |
- |
- |
- |
- |
041 [3] 41, 269, 271 💬 |
477 |
Cosentyx® |
- |
- |
- |
- |
269 [1] 269 💬 |
478 |
Cosmofer |
- |
- |
- |
- |
086 [3] 86, 96, 97 💬 |
479 |
Cosmofer 50mg/ml solution for infusion or injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
480 |
Costicosteroids |
- |
- |
- |
- |
026 [1] 26 💬 |
481 |
Cosyntropin |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
083 [3] 83, 113, 145 💬 |
482 |
Cosyntropin acetate |
Acetate |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
113 [1] 113 💬 |
483 |
Cosyntropin injectable suspension 1 mg/ml + vigabatrin |
Tetracosactide |
[2] D00284 D00284, D00535 D00535 💬 |
ABAT [2] ABAT, MC2R 💬 |
Alanine, aspartate and glutamate metabolism [12] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway |
145 [1] 145 💬 |
484 |
Cosyntropin injectable suspension, 1 mg/ml |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
145 [1] 145 💬 |
485 |
Cotrimoxazole |
- |
- |
- |
- |
085 [2] 85, 97 💬 |
486 |
Cotton |
Cotton |
- |
- |
- |
035 [2] 35, 162 💬 |
487 |
Coversin |
Nomacopan |
[1] D11473 D11473 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [2] 62, 109 💬 |
488 |
Coversyl |
- |
- |
- |
- |
019 [2] 19, 167 💬 |
489 |
Coversyl (perindopril) |
Perindopril |
[2] D00624 D00624, D03753 D03753 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
167 [1] 167 💬 |
490 |
Coversyl plus |
- |
- |
- |
- |
019 [1] 19 💬 |
491 |
Cozaar |
- |
- |
- |
- |
167 [1] 167 💬 |
492 |
Cozaar 50 |
- |
- |
- |
- |
167 [1] 167 💬 |
493 |
Cozaar 50 mg comprimidos recubierto con pelicula |
- |
- |
- |
- |
179 [1] 179 💬 |
494 |
Cozaar inicio 12,5 mg comprimidos recubiertos con pelicula |
- |
- |
- |
- |
167 [1] 167 💬 |
495 |
Crestor film-coated tablet |
- |
- |
- |
- |
079 [1] 79 💬 |
496 |
Crestor tablets (calcium rosuvastatin) film-coated tablets |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 [1] 79 💬 |
497 |
Cryopreserved autologous cd34+ cells transduced with a lentiviral vector containing human sgsh gene |
- |
- |
- |
- |
019 [1] 19 💬 |
498 |
Cs (corticosteroids) only |
- |
- |
- |
- |
097 [1] 97 💬 |
499 |
Csm allogéniques issues de cordons ombilicaux ( mti-pp) |
- |
- |
- |
- |
049 [1] 49 💬 |
500 |
Cumulative corticosteroid exposure |
- |
- |
- |
- |
049 [1] 49 💬 |
501 |
Cuprior 150 mg film-coated tablets |
- |
- |
- |
- |
171 [1] 171 💬 |
502 |
Cuprior 150mg film-coated tablets |
- |
- |
- |
- |
171 [1] 171 💬 |
503 |
Currently available therapy in the community |
- |
- |
- |
- |
051 [1] 51 💬 |
504 |
Cushing's syndrome confirmation |
- |
- |
- |
- |
075 [1] 75 💬 |
505 |
Cyclophosphamide/glatiramer acetate |
Acetate |
[3] D00287 D00287, D04318 D04318, D07760 D07760 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
506 |
Cyclosporine combine with mycophenolate mofetil |
Cyclosporine |
[5] D00184 D00184, D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [7] IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [35] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
283 [1] 283 💬 |
507 |
Cytotoxic combination |
- |
- |
- |
- |
056 [1] 56 💬 |
508 |
D-methylphenidate |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
084 [1] 84 💬 |
509 |
D-sorbitol |
Sorbitol |
[1] D00096 D00096 💬 |
- |
- |
010 [1] 10 💬 |
510 |
D.3.2 product code where applicable13: |
- |
- |
- |
- |
193 [1] 193 💬 |
511 |
Daratumumab co-formulated with recombinant human hyaluronidase (rhuph20) |
Daratumumab |
[4] D04455 D04455, D04456 D04456, D06604 D06604, D10777 D10777 💬 |
CD38 [1] CD38 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
028 [1] 28 💬 |
512 |
Dark chocolate (85% cocoa) |
Cocoa |
- |
- |
- |
006 [1] 6 💬 |
513 |
Data collection |
- |
- |
- |
- |
065 [1] 65 💬 |
514 |
Decortin (prednisona) 5 mg comprimidos |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
515 |
Depot tetracosactide |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
083 [1] 83 💬 |
516 |
Device: 129xe small and large human lung coil |
- |
- |
- |
- |
299 [1] 299 💬 |
517 |
Device: 3he human lung coil |
- |
- |
- |
- |
299 [1] 299 💬 |
518 |
Device: abatacept combination product (acp) |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 [1] 46 💬 |
519 |
Device: abdominal compression |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
520 |
Device: auto-titrating oxygen system |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
521 |
Device: c-stem™ amt femoral component (standard and high off-set variants) |
- |
- |
- |
- |
046 [1] 46 💬 |
522 |
Device: capacity of muscular oxygen extraction |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
013 [1] 13 💬 |
523 |
Device: cellvizio 100 series system with confocal miniprobes |
- |
- |
- |
- |
215 [1] 215 💬 |
524 |
Device: cervical orthosis (co) |
- |
- |
- |
- |
070 [1] 70 💬 |
525 |
Device: cobalt™ bone cement |
Cobalt |
- |
- |
- |
046 [1] 46 💬 |
526 |
Device: continuous glucose monitor |
Dextrose, unspecified form |
- |
- |
- |
065 [1] 65 💬 |
527 |
Device: continuous glucose monitor (cgm) |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
528 |
Device: continuous glucose monitoring |
Dextrose, unspecified form |
- |
- |
- |
075 [2] 75, 299 💬 |
529 |
Device: contrast enhanced ultrasound |
- |
- |
- |
- |
096 [1] 96 💬 |
530 |
Device: conventional syringe - bd ref 309604 |
- |
- |
- |
- |
046 [1] 46 💬 |
531 |
Device: cotton gauze with petrolatum |
Cotton |
[2] D05304 D05304, D05331 D05331 💬 |
- |
- |
035 [2] 35, 162 💬 |
532 |
Device: fourier domain doppler optical coherence tomography (fdoct) |
- |
- |
- |
- |
013 [1] 13 💬 |
533 |
Device: high flow nasal oxygen cannula |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
534 |
Device: high-resolution peripheral quantitative computed tomography (hr-pqct) |
- |
- |
- |
- |
046 [1] 46 💬 |
535 |
Device: hyperbaric oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
046 [1] 46 💬 |
536 |
Device: in utero endoscopic correction of myelomeningocele ide - laparotomy/uterine exteriorization technique |
- |
- |
- |
- |
118 [1] 118 💬 |
537 |
Device: in utero endoscopic correction of myelomeningocele ide - percutaneous technique |
- |
- |
- |
- |
118 [1] 118 💬 |
538 |
Device: intermittent exposure to oxygen via oro-nasal mask |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
226 [1] 226 💬 |
539 |
Device: light box ( litebook company) |
- |
- |
- |
- |
006 [1] 6 💬 |
540 |
Device: light box (litebook company) |
- |
- |
- |
- |
006 [1] 6 💬 |
541 |
Device: manual toothbrush and water flosser (philips sonicare airfloss) |
Water |
[1] D00001 D00001 💬 |
- |
- |
051 [1] 51 💬 |
542 |
Device: mri with contrast agent injection |
- |
- |
- |
- |
019 [1] 19 💬 |
543 |
Device: mri without contrast agent injection |
- |
- |
- |
- |
019 [1] 19 💬 |
544 |
Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
545 |
Device: optical coherence tomography (oct) |
- |
- |
- |
- |
013 [1] 13 💬 |
546 |
Device: optical coherence tomography angiography (octa) |
- |
- |
- |
- |
013 [1] 13 💬 |
547 |
Device: oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
548 |
Device: oxygen saturation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
084 [1] 84 💬 |
549 |
Device: oxymizer® compared to cnc |
- |
- |
- |
- |
085 [1] 85 💬 |
550 |
Device: pfp and sf6 human lung coil |
- |
- |
- |
- |
299 [1] 299 💬 |
551 |
Device: sham compression |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
552 |
Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss) |
Water |
[1] D00001 D00001 💬 |
- |
- |
051 [1] 51 💬 |
553 |
Device: standard oxygen therapy/ra |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
554 |
Device: the colonic transendoscopic enteral tubing. |
- |
- |
- |
- |
097 [1] 97 💬 |
555 |
Device: voluntary peak cough flow testing |
- |
- |
- |
- |
002 [1] 2 💬 |
556 |
Dexamethasone (50mg 1dd6, 3 consecutive days/month) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
557 |
Dextrose, 5% in water |
Dextrose, unspecified form |
[1] D00001 D00001 💬 |
- |
- |
065 [1] 65 💬 |
558 |
Diagnostic test: adalimumab serum trough concentration |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
559 |
Diagnostic test: adalimumab trough concentration |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
560 |
Diagnostic test: blood drawing in healthy controls |
- |
- |
- |
- |
065 [1] 65 💬 |
561 |
Diagnostic test: colchicine level measurement |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
562 |
Diagnostic test: colonoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
563 |
Diagnostic test: continuous glucose monitoring |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
564 |
Diagnostic test: cosyntropin stimulation test |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
083 [1] 83 💬 |
565 |
Diagnostic test: fibrinogen plasma concentration, coagulation factor xiii activity |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
566 |
Diagnostic test: maximum oxygen uptake |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
294 [1] 294 💬 |
567 |
Diagnostic test: mini cognitive examination (mce) |
- |
- |
- |
- |
006 [1] 6 💬 |
568 |
Diagnostic test: ocular coherence tomography-angiography (oct-a) |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
569 |
Diagnostic test: p-mpa concentration |
- |
- |
- |
- |
051 [1] 51 💬 |
570 |
Diagnostic test: parasitological diagnostics (coproscopy) |
- |
- |
- |
- |
097 [1] 97 💬 |
571 |
Diagnostic test: rey-osterrieth complex figure test (rocft) |
- |
- |
- |
- |
006 [1] 6 💬 |
572 |
Diagnostic test: serum metal ion levels determined to monitor changes in chromium and cobalt levels |
Chromium |
- |
- |
- |
046 [1] 46 💬 |
573 |
Diagnostic test: simultaneous combined 18f-fdg pet and cardiac mri imaging |
Fludeoxyglucose (18F) |
- |
- |
- |
084 [1] 84 💬 |
574 |
Diagnostic test: spanish-complutense verbal learning test (tavec) |
- |
- |
- |
- |
006 [1] 6 💬 |
575 |
Diazoxide choline controlled-release tablet |
Choline |
[2] D00294 D00294, D07690 D07690 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 [1] 193 💬 |
576 |
Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon |
Ammonium chloride |
[1] D01139 D01139 💬 |
- |
- |
096 [1] 96 💬 |
577 |
Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) |
Amiodarone |
[2] D00636 D00636, D02910 D02910 💬 |
ADRA1A [16] ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [31] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 [1] 28 💬 |
578 |
Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus egcg |
Amiodarone |
[2] D00636 D00636, D02910 D02910 💬 |
ADRA1A [16] ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [31] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 [1] 28 💬 |
579 |
Dmso cocktail |
Dimethyl sulfoxide |
[1] D01043 D01043 💬 |
- |
- |
226 [1] 226 💬 |
580 |
Dmt continuation |
- |
- |
- |
- |
013 [1] 13 💬 |
581 |
Doptelet 20 mg film-coated tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
582 |
Drug free, is monotherapy and gc combined with is |
- |
- |
- |
- |
300 [1] 300 💬 |
583 |
Dual release hydrocortisone (plenadren) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
584 |
E. coli nissle |
- |
- |
- |
- |
097 [1] 97 💬 |
585 |
Echo and myocardial contrast echocardiography perfusion imaging |
- |
- |
- |
- |
058 [1] 58 💬 |
586 |
Eflornithine plus nifurtimox combination therapy |
Eflornithine |
[2] D00833 D00833, D07883 D07883 💬 |
ODC1 [1] ODC1 💬 |
Arginine and proline metabolism [3] Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways |
065 [1] 65 💬 |
587 |
Eltrombopag combining rituximab |
Eltrombopag |
[2] D02994 D02994, D03978 D03978 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
588 |
Enalapril and other angiotensin converting enzyme inhibitors |
Angiotensin II |
[4] D00150 D00150, D00621 D00621, D02014 D02014, D07892 D07892 💬 |
ACE [3] ACE, AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 [1] 19 💬 |
589 |
Endoprost - 0.05 mg/0.5 ml concentrato per soluzione per infusione 1 fiala |
- |
- |
- |
- |
051 [1] 51 💬 |
590 |
Entacapone |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
591 |
Entacapone 400mg oral dose |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
592 |
Entacapone and carbidopa |
Carbidopa |
[2] D00558 D00558, D00781 D00781 💬 |
COMT [2] COMT, DDC 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
593 |
Entacapone inn |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
594 |
Enteric coated mycophenolate sodium |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
228 [1] 228 💬 |
595 |
Enteric-coated mycophenolate sodium |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 [1] 49 💬 |
596 |
Epilim chrono 200 controlled released tablets |
- |
- |
- |
- |
256 [1] 256 💬 |
597 |
Epilim chrono 300 controlled released tablets |
- |
- |
- |
- |
256 [1] 256 💬 |
598 |
Epilim chrono 500 controlled released tablets |
- |
- |
- |
- |
256 [1] 256 💬 |
599 |
Epinephrine |
Epinephrine |
[3] D00095 D00095, D00996 D00996, D02149 D02149 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [2] 46, 96 💬 |
600 |
Etanercept, methotrexate, prednisolone |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
056 [1] 56 💬 |
601 |
Etims (edc-fixed autologous pbmcs coupled with 7 immunodominant myelin peptides in ms patients) |
- |
- |
- |
- |
013 [1] 13 💬 |
602 |
Ev substance code: sub188638 |
- |
- |
- |
- |
113 [1] 113 💬 |
603 |
Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length lamb3 cdna. |
- |
- |
- |
- |
036 [1] 36 💬 |
604 |
Experimental glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
605 |
Extension cohort |
- |
- |
- |
- |
060 [1] 60 💬 |
606 |
Ezetimibe+simvastatin drug combination |
Ezetimibe |
[2] D00434 D00434, D01966 D01966 💬 |
HMGCR [2] HMGCR, NPC1L1 💬 |
AMPK signaling pathway [5] AMPK signaling pathway, Bile secretion, Fat digestion and absorption, Metabolic pathways, Terpenoid backbone biosynthesis |
049 [1] 49 💬 |
607 |
Fabrazyme - 35 mg polvere per concentrato per soluzione per infusione endovenosa 1 flaconcino |
- |
- |
- |
- |
019 [1] 19 💬 |
608 |
Factor viii concentrate |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
609 |
Factor xiii concentrate (human) |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
610 |
Factor xiii concentrate (human), pasteurized |
Factor XIII (human) |
- |
- |
- |
288 [1] 288 💬 |
611 |
Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) |
- |
- |
- |
- |
013 [1] 13 💬 |
612 |
Fdl176 & fdl169 coadministration |
- |
- |
- |
- |
299 [1] 299 💬 |
613 |
Fenfluramine hydrochloride (colorless) |
Fenfluramine |
[1] D07945 D07945 💬 |
HTR2A [4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 [2] 140, 144 💬 |
614 |
Ferinject or cosmofer |
- |
- |
- |
- |
086 [1] 86 💬 |
615 |
Fibrinogen (coagulation factori) |
Fibrinogen human |
- |
- |
- |
065 [1] 65 💬 |
616 |
Fibrinogen concentrate |
Fibrinogen human |
- |
- |
- |
014 [1] 14 💬 |
617 |
Fibrinogen concentrate from human plasma |
Fibrinogen human |
- |
- |
- |
065 [1] 65 💬 |
618 |
Fibrogammin®p, coagulation factor xiii concentrate (human) |
Factor XIII (human) |
- |
- |
- |
051 [1] 51 💬 |
619 |
Film-coated tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
620 |
Fipamezole odt cohort 2 |
Fipamezole |
- |
- |
- |
006 [1] 6 💬 |
621 |
Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse |
- |
- |
- |
- |
011 [1] 11 💬 |
622 |
Fish oil concentrate |
Fish oil |
- |
- |
- |
013 [1] 13 💬 |
623 |
Fixed dose combination ciprofloxacin/celecoxib |
Celecoxib |
[3] D00186 D00186, D00567 D00567, D02216 D02216 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 [1] 2 💬 |
624 |
Flaxseed lignan-enriched complex (flc) |
- |
- |
- |
- |
097 [1] 97 💬 |
625 |
Fludarabina accord - 25 mg/ml concentrato per soluzione iniettabile o per infusione 5 flaconcini in vetro da 2 ml |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 [1] 19 💬 |
626 |
Fludarabina teva - 25 mg/ml concentrato per soluzione iniettabile o per infusione 1 flaconcino di vetro da 2 ml |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [1] 65 💬 |
627 |
Formistin - 10 mg compresse rivestite con film 20 compresse |
- |
- |
- |
- |
013 [1] 13 💬 |
628 |
Fostamatinib 50 mg blue film-coated tablet |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
629 |
Fxiii concentrate (human) |
- |
- |
- |
- |
288 [1] 288 💬 |
630 |
Fxiii concentrate (human) (fxiii) |
- |
- |
- |
- |
288 [1] 288 💬 |
631 |
G-csf for conditioning before hsct. |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
065 [1] 65 💬 |
632 |
Gaboxadol monohydrate 0.5 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
633 |
Gaboxadol monohydrate 2 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
634 |
Gaboxadol monohydrate 5 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
635 |
Gadolinium contrast |
Gadolinium |
- |
- |
- |
034 [1] 34 💬 |
636 |
Gadolinium-based contrast |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
637 |
Gelatin |
Gelatin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
028 [4] 28, 78, 97, 269 💬 |
638 |
General corticotherapy |
- |
- |
- |
- |
035 [1] 35 💬 |
639 |
Genetic: amplification by pcr and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene |
- |
- |
- |
- |
265 [1] 265 💬 |
640 |
Genetic: blood or saliva sample collection |
- |
- |
- |
- |
299 [1] 299 💬 |
641 |
Genetic: recombinant adenovirus containing the ornithine transcarbamylase gene |
Ornithine |
[1] D08302 D08302 💬 |
- |
- |
251 [1] 251 💬 |
642 |
Genetically corrected cultured epidermal autograft (atmp) |
- |
- |
- |
- |
036 [1] 36 💬 |
643 |
Genotropin (somatropin) is a growth hormone treatment. it is an exact copy of the natural growth hormone that our bodies make. the main difference is that genotropin is man-made. |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
193 [1] 193 💬 |
644 |
Glatiramer |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 [4] 2 , 13, 96, 156 💬 |
645 |
Glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [3] 13, 96, 156 💬 |
646 |
Glatiramer acetate (copaxone®) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [2] 13, 156 💬 |
647 |
Glatiramer acetate (db) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
648 |
Glatiramer acetate (ga) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
649 |
Glatiramer acetate (ga) 40 mg |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
650 |
Glatiramer acetate (gtr) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
651 |
Glatiramer acetate (ol) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
652 |
Glatiramer acetate 150mg enteric coated tablets |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
653 |
Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
654 |
Glatiramer acetate 20 mg |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
655 |
Glatiramer acetate 20 mg, with mitoxantrone |
Acetate |
[3] D02166 D02166, D04318 D04318, D08224 D08224 💬 |
HLA-A [22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬 |
Allograft rejection [33] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
656 |
Glatiramer acetate 20 mg/0.5 ml |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
657 |
Glatiramer acetate 40 mg |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
658 |
Glatiramer acetate [ga] |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
659 |
Glatiramer acetate injection with oral cetirizine hydrochloride |
Acetate |
[3] D00664 D00664, D04318 D04318, D07662 D07662 💬 |
HLA-A [21] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬 |
Allograft rejection [35] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
660 |
Glatiramer acetate with minocycline |
Acetate |
[3] D00850 D00850, D04318 D04318, D05045 D05045 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
661 |
Glatiramer acetate, (copaxone®) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
662 |
Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
663 |
Glatiramer acetate, n-acetylcysteine |
Acetate |
[2] D00221 D00221, D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
664 |
Glatiramer acetato |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
665 |
Glivec 100 mg comprimidos recubiertos con película |
- |
- |
- |
- |
034 [2] 34, 86 💬 |
666 |
Glivec 400 mg comprimidos recubiertos con película |
- |
- |
- |
- |
034 [1] 34 💬 |
667 |
Glucocorticoid (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
668 |
Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim) |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 [1] 229 💬 |
669 |
Granulocyte - colony stimulating factor (g-csf) |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [1] 2 💬 |
670 |
Granulocyte colony stimulating factor |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [6] 2 , 28, 36, 57, 65, 85 💬 |
671 |
Granulocyte colony stimulating factor (g-csf) |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
065 [1] 65 💬 |
672 |
Granulocyte colony stimulating factor (gcsf) |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
036 [2] 36, 57 💬 |
673 |
Granulocyte colony-stimulating factor |
- |
- |
- |
- |
296 [1] 296 💬 |
674 |
Granulocyte colony-stimulating factor (filgrastim) |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
113 [1] 113 💬 |
675 |
Granulocyte-colony stimulating factor (g-csf) and prednisone |
Filgrastim |
[2] D00473 D00473, D03235 D03235 💬 |
CSF3R [2] CSF3R, NR3C1 💬 |
Cytokine-cytokine receptor interaction [6] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer |
013 [1] 13 💬 |
676 |
Granulocyte-macrophage colony stimulating factor (gm-csf) |
- |
- |
- |
- |
229 [1] 229 💬 |
677 |
Granulocyte-macrophage colony-stimulating factor (gm-csf) |
- |
- |
- |
- |
011 [1] 11 💬 |
678 |
Group 1- control diet |
- |
- |
- |
- |
097 [1] 97 💬 |
679 |
Growth colony stimulating factor (g-csf) |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
049 [1] 49 💬 |
680 |
Gsk1265744b (sodium salt) containing 14c-gsk1265744b |
- |
- |
- |
- |
265 [1] 265 💬 |
681 |
H.p. acthar gel (repository corticotropin injection) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [1] 13 💬 |
682 |
Haemate p® (human coagulation factor viii) |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
683 |
Haplo/cord transplant |
- |
- |
- |
- |
060 [1] 60 💬 |
684 |
Hcq/cq and cab combined treatment |
- |
- |
- |
- |
074 [1] 74 💬 |
685 |
Helium / oxygen mixed gas inhalation therapy |
Helium |
[2] D00003 D00003, D04420 D04420 💬 |
- |
- |
330 [1] 330 💬 |
686 |
Heparin & alkalinized lidocaine bladder instillation |
Heparin |
[4] D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A [6] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes [4] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
687 |
High dose vehicle control |
- |
- |
- |
- |
046 [1] 46 💬 |
688 |
High water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
689 |
Hiomega-3 supplement of naturalis® company - |
- |
- |
- |
- |
049 [1] 49 💬 |
690 |
Histamine |
Histamine |
[1] D08040 D08040 💬 |
HRH1 [4] HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
691 |
Hmg-coenzyme inhibitor (statin) |
- |
- |
- |
- |
218 [1] 218 💬 |
692 |
Hov-12020 (palm tocotrienols complex) |
- |
- |
- |
- |
124 [1] 124 💬 |
693 |
Human coagulation factor viii |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
694 |
Human coagulation factor viii / von willebrand factor |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
695 |
Human coagulation factor viii associated with von willebrand factor (vwf) |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
696 |
Human coagulation factor viii, von willebrand factor complex |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
697 |
Human fibrinogen concentrate |
Fibrinogen human |
- |
- |
- |
065 [1] 65 💬 |
698 |
Human interferon beta-1a and glatiramer acetate |
Acetate |
[2] D04318 D04318, D04554 D04554 💬 |
HLA-A [22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNAR1, IFNAR2 💬 |
Allograft rejection [44] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
699 |
Human monoclonal antibody directed against complement 5 protein |
- |
- |
- |
- |
062 [1] 62 💬 |
700 |
Human umbilical cord blood-derived mesenchymal stem cells |
- |
- |
- |
- |
036 [1] 36 💬 |
701 |
Human umbilical cord derived msc transplantation for sle |
- |
- |
- |
- |
049 [1] 49 💬 |
702 |
Human umbilical cord mesenchymal stem cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
013 [2] 13, 113 💬 |
703 |
Human umbilical cord-derived mscs |
- |
- |
- |
- |
271 [1] 271 💬 |
704 |
Human von willebrand factor (vwf) and coagulation factor viii (fviii) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
705 |
Human vwf/fviii concentrate |
- |
- |
- |
- |
288 [1] 288 💬 |
706 |
Hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [9] 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
707 |
Hydrocortisone (solucortef) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
708 |
Hydrocortisone 100mg/ml |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
709 |
Hydrocortisone 10mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
710 |
Hydrocortisone 10mg tablet |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
711 |
Hydrocortisone 10mg tablets |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
712 |
Hydrocortisone 20mg tablets |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
713 |
Hydrocortisone acetate |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
714 |
Hydrocortisone cream |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
715 |
Hydrocortisone cream 1% |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
716 |
Hydrocortisone cream 10mg/g fna fagron |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
717 |
Hydrocortisone hydrogen succinate |
Hydrocortisone |
[2] D00088 D00088, D01442 D01442 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
718 |
Hydrocortisone modified release capsules |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
719 |
Hydrocortisone roussel |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
720 |
Hydrocortisone sodium acetate |
Acetate |
[2] D00088 D00088, D01779 D01779 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
721 |
Hydrocortisone sodium phosphate |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
053 [3] 53, 81, 83 💬 |
722 |
Hydrocortisone sodium succinate |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [3] 81, 83, 97 💬 |
723 |
Hydrocortisone tablet 2.5 mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
724 |
Hydrocortisone takeda, tabletter |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
725 |
Hyperglycemic clamp with concurrent gip infusion |
- |
- |
- |
- |
299 [1] 299 💬 |
726 |
Hyperglycemic clamp with concurrent glp-1 infusion |
- |
- |
- |
- |
299 [1] 299 💬 |
727 |
Hyperpolarized 129 xenon gas comparing idiopathic pulmonary fibrosis (ipf) treatment |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
085 [1] 85 💬 |
728 |
Ic cocktail |
- |
- |
- |
- |
226 [1] 226 💬 |
729 |
Idebenone 150 mg film-coated tablets |
Idebenone |
[1] D01750 D01750 💬 |
- |
- |
113 [1] 113 💬 |
730 |
Immunosuppression only conditioning (ioc) |
- |
- |
- |
- |
065 [1] 65 💬 |
731 |
Immunosuppression only conditioning - closed with amendment l |
- |
- |
- |
- |
065 [1] 65 💬 |
732 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
733 |
Infliximab and azathioprine combination at week 0 |
Azathioprine |
[3] D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
734 |
Infliximab and azathioprine combination at week 14 |
Azathioprine |
[3] D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
735 |
Infliximab control |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
736 |
Inhibace/cozaar |
- |
- |
- |
- |
066 [1] 66 💬 |
737 |
Injection of umbilical cord derived mscs |
- |
- |
- |
- |
006 [1] 6 💬 |
738 |
Inn colecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [1] 13 💬 |
739 |
Intra-articular compound betamethasone |
Betamethasone |
[7] D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
740 |
Intraarticular morphine |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
741 |
Intravenous methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [1] 43 💬 |
742 |
Iron sucrose |
Iron sucrose |
[2] D00025 D00025, D04616 D04616 💬 |
- |
- |
062 [3] 62, 96, 97 💬 |
743 |
Iron sulphate 200mg coated tablets |
Iron |
- |
- |
- |
096 [2] 96, 97 💬 |
744 |
Iron(iii)- hydroxide dextran complex |
Dextran |
[1] D00060 D00060 💬 |
- |
- |
096 [2] 96, 97 💬 |
745 |
Isotonic sodium chloride solution |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
034 [1] 34 💬 |
746 |
Iv corticosteroid |
- |
- |
- |
- |
097 [1] 97 💬 |
747 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
748 |
Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
749 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
750 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 [1] 67 💬 |
751 |
Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 [1] 67 💬 |
752 |
Jnj-38518168-zbq - film-coated tablet - 10 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
753 |
Jnj-38518168-zbq - film-coated tablet - 10mg |
- |
- |
- |
- |
046 [1] 46 💬 |
754 |
Jnj-38518168-zbq - film-coated tablet - 3 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
755 |
Jnj-38518168-zbq - film-coated tablet - 30 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
756 |
Jnj-38518168-zbq - film-coated tablet - 30mg |
- |
- |
- |
- |
046 [1] 46 💬 |
757 |
Jnj-38518168-zbq - film-coated tablet - 3mg |
- |
- |
- |
- |
046 [1] 46 💬 |
758 |
Jnj-39758979-aac - enteric coated tablet - 10 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
759 |
Jnj-39758979-aac - enteric coated tablet - 100 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
760 |
Jnj-39758979-aac - enteric coated tablet - 30 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
761 |
Kalydeco 150 mg film-coated tablets |
- |
- |
- |
- |
299 [1] 299 💬 |
762 |
Kvd900 100 mg film coated tablet |
- |
- |
- |
- |
065 [1] 65 💬 |
763 |
L01x co2 |
- |
- |
- |
- |
046 [1] 46 💬 |
764 |
L04aa04 - immunoglobulina antitimocitaria (di coniglio) immunoglobulina di coniglio antitimociti umani thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [1] 13 💬 |
765 |
Lactose in water |
Lactose |
[3] D00001 D00001, D00046 D00046, D03226 D03226 💬 |
- |
- |
097 [1] 97 💬 |
766 |
Lap tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
767 |
Lentiviral vector containing abca4 gene |
- |
- |
- |
- |
301 [1] 301 💬 |
768 |
Lentiviral vector containing myo7a gene |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
769 |
Lentiviral vector containing the human my07a gene |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
770 |
Levodopa cr (controlled release) |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
771 |
Levodopa, carbidopa, entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
772 |
Levodopa, decarboxylase inhibitor and comt inhibitor |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
773 |
Levodopa-carbidopa-entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
774 |
Levodopa/carbidopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
775 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
776 |
Lidocaine 1% injectable solution |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
034 [1] 34 💬 |
777 |
Lidocaine 2% without vessel constrictor |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [1] 51 💬 |
778 |
Lidocaine injection 2% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
168 [1] 168 💬 |
779 |
Lidocaine patch 5% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
780 |
Lidocaine releasing intravesical system - liris® |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
226 [1] 226 💬 |
781 |
Linaclotide |
Linaclotide |
[1] D09355 D09355 💬 |
GUCY2C [1] GUCY2C 💬 |
Metabolic pathways [2] Metabolic pathways, Purine metabolism |
097 [1] 97 💬 |
782 |
Lipasa ácida lisosómica, esterasa, colesterol (gen humano lipa), lipasa ácida lisosómica (gen humano lipa) |
- |
- |
- |
- |
019 [1] 19 💬 |
783 |
Lisinopril, losartan, and atorvastatin |
Atorvastatin |
[7] D00258 D00258, D00357 D00357, D00362 D00362, D00887 D00887, D07474 D07474, D08131 D08131, D08146 D08146 💬 |
ACE [3] ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
784 |
Lo-ovral oral contraceptive pills |
- |
- |
- |
- |
060 [1] 60 💬 |
785 |
Local anesthesia (lidocaine hydrochloride) |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
786 |
Locally approved intravenous contrast medium for contrast enhanced mri |
- |
- |
- |
- |
013 [1] 13 💬 |
787 |
Lodotra (delayed release prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
788 |
Long-circulating liposomal prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
789 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
790 |
Losartan and atenolol or propranolol |
Atenolol |
[5] D00235 D00235, D00357 D00357, D00483 D00483, D08146 D08146, D08443 D08443 💬 |
ADRB1 [4] ADRB1, ADRB2, ADRB3, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
791 |
Losartan and nebivolol |
Losartan |
[3] D00357 D00357, D05127 D05127, D08146 D08146 💬 |
ADRB1 [2] ADRB1, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [21] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
792 |
Losartan and other angiotensin receptor blockers |
Angiotensin II |
[4] D00150 D00150, D00357 D00357, D02014 D02014, D08146 D08146 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 [1] 19 💬 |
793 |
Losartan bluefish 50 mg |
Bluefish |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
794 |
Losartan hexal |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 [1] 36 💬 |
795 |
Losartan potasico |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
179 [1] 179 💬 |
796 |
Losartan potassium |
Losartan |
[3] D00357 D00357, D08146 D08146, D08403 D08403 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 [5] 36, 98, 167, 179, 215 💬 |
797 |
Losartan tablets & qingremoshen granule |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
798 |
Low antigen content diet |
- |
- |
- |
- |
066 [1] 66 💬 |
799 |
Low dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
800 |
Low dose vehicle control |
- |
- |
- |
- |
046 [1] 46 💬 |
801 |
Lum/iva fixed-dose combination |
- |
- |
- |
- |
299 [1] 299 💬 |
802 |
Lumacaftor plus ivacaftor combination |
Ivacaftor |
[2] D09916 D09916, D10134 D10134 💬 |
CFTR [1] CFTR 💬 |
ABC transporters [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 [1] 299 💬 |
803 |
Lumacaftor, ivacaftor drug combination |
Ivacaftor |
[2] D09916 D09916, D10134 D10134 💬 |
CFTR [1] CFTR 💬 |
ABC transporters [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 [1] 299 💬 |
804 |
Lzrse-col7a1 engineered autologous epidermal sheets |
- |
- |
- |
- |
036 [1] 36 💬 |
805 |
Mabcampath 10 mg/ml concentrado para solución para perfusión |
- |
- |
- |
- |
013 [1] 13 💬 |
806 |
Mabthera 100 mg concentrate for solution for infusion |
- |
- |
- |
- |
222 [1] 222 💬 |
807 |
Mabthera 500 mg (10 mg/ml) concentrate for solution for infusion |
- |
- |
- |
- |
046 [1] 46 💬 |
808 |
Mabthera 500 mg concentrado para solución para perfusión |
- |
- |
- |
- |
046 [1] 46 💬 |
809 |
Mabthera 500 mg concentrate for solution for infusion |
- |
- |
- |
- |
046 [2] 46, 222 💬 |
810 |
Mabthera®, 100 mg concentrado para solución para perfusión |
- |
- |
- |
- |
046 [1] 46 💬 |
811 |
Mabthera®, 100 mg concentrate for solution for infusion |
- |
- |
- |
- |
046 [1] 46 💬 |
812 |
Magnesium sulfate |
Magnesium |
[1] D01108 D01108 💬 |
- |
- |
011 [3] 11, 296, 297 💬 |
813 |
Marketed plasma-derived vwf/fviii concentrate |
- |
- |
- |
- |
288 [1] 288 💬 |
814 |
Medical air vs oxygen |
Medical air |
[1] D00003 D00003 💬 |
- |
- |
193 [1] 193 💬 |
815 |
Medical grade oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
816 |
Medium dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
817 |
Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) |
- |
- |
- |
- |
013 [1] 13 💬 |
818 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
[2] D00088 D00088, D00377 D00377 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
819 |
Metabolic cofactor supplementation |
- |
- |
- |
- |
006 [1] 6 💬 |
820 |
Metformina - 500 30 compresse 500 mg |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 [1] 113 💬 |
821 |
Methotrexate - etanercept - prednisolone arm |
Etanercept |
[11] D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
822 |
Methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [3] 43, 49, 96 💬 |
823 |
Methylphenidate |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [7] 6 , 13, 34, 84, 113, 179, 206 💬 |
824 |
Methylphenidate (mpd) |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [1] 6 💬 |
825 |
Methylphenidate (overencapsulated) |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
084 [1] 84 💬 |
826 |
Methylphenidate 10mg tablets |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
084 [1] 84 💬 |
827 |
Methylphenidate hydrochloride |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [2] 6 , 13 💬 |
828 |
Methylphenidate modified release |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
829 |
Methylphenidate modified release 20 mg |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
830 |
Methylphenidate modified release 30 mg |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
831 |
Methylphenidate modified release 40 mg |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
832 |
Methylphenidate, fluoxetin, risperidone |
Fluoxetine |
[5] D00326 D00326, D00426 D00426, D00823 D00823, D01296 D01296, D04999 D04999 💬 |
DRD2 [5] DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway |
179 [2] 179, 206 💬 |
833 |
Methylprednisolone or prednisolone |
Methylprednisolone |
[14] D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
834 |
Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al |
Metoclopramide |
[3] D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 [1] 51 💬 |
835 |
Metopirone 250 mg capsules/cormeto |
- |
- |
- |
- |
075 [1] 75 💬 |
836 |
Metotrexato sandoz - 2.5 mg compresse 50 compresse in flacone pp |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
837 |
Metotrexato-lederle 2,5 mg comprimidos |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
838 |
Microgynon® 30 (oral contraceptive) |
- |
- |
- |
- |
046 [1] 46 💬 |
839 |
Minocycline 100 mg film-coated tablets |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
013 [1] 13 💬 |
840 |
Modified cobratoxin |
- |
- |
- |
- |
020 [1] 20 💬 |
841 |
Morphine |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 [5] 36, 46, 70, 85, 86 💬 |
842 |
Morphine hexal |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
843 |
Morphine hydrochloride |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
844 |
Morphine pca |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
845 |
Morphine sulfate |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [3] 46, 85, 86 💬 |
846 |
Morphine sulphate in intrasite gel |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 [1] 36 💬 |
847 |
Myeloablative conditioning regimen |
- |
- |
- |
- |
164 [1] 164 💬 |
848 |
Myeloablative conditioning-closed with amendment l |
- |
- |
- |
- |
065 [1] 65 💬 |
849 |
Myozyme 50 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
256 [1] 256 💬 |
850 |
Méthotrexate bellon comprimé |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
271 [1] 271 💬 |
851 |
Nebulized combination ipratropium bromide with salbutamol |
Ipratropium |
[2] D02147 D02147, D02212 D02212 💬 |
ADRB2 [6] ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes [17] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
852 |
Neoral soft gelatin capsules |
Gelatin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
097 [2] 97, 269 💬 |
853 |
Nerixia*infus iv conc 2f 100mg |
- |
- |
- |
- |
274 [1] 274 💬 |
854 |
Nifurtimox-eflronithine combination treatment (nect) |
Nifurtimox |
[1] D00833 D00833 💬 |
- |
- |
065 [1] 65 💬 |
855 |
Nitisinone 10 mg tablet high compritol |
Nitisinone |
[1] D05177 D05177 💬 |
HPD [1] HPD 💬 |
Biosynthesis of cofactors [5] Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis |
241 [1] 241 💬 |
856 |
Nitric oxide plus oxygen |
Nitric Oxide |
[2] D00003 D00003, D00074 D00074 💬 |
- |
- |
086 [1] 86 💬 |
857 |
Non atg conditioning regimen |
- |
- |
- |
- |
060 [1] 60 💬 |
858 |
Norvir 100 mg film-coated tablets |
- |
- |
- |
- |
299 [1] 299 💬 |
859 |
Novartis pharmaceuticals corporation |
- |
- |
- |
- |
013 [1] 13 💬 |
860 |
Nutraceutical combination |
- |
- |
- |
- |
096 [1] 96 💬 |
861 |
Nutritional formulation containing exogenous ketones |
- |
- |
- |
- |
201 [1] 201 💬 |
862 |
Ondansetron 8 mg film-coated tablets |
Ondansetron |
[2] D00456 D00456, D00678 D00678 💬 |
HTR3A [5] HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse [2] Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
863 |
Optivate® (human coagulation factor viii) |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
864 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
[7] D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
865 |
Oral bovine type i collagen |
Bovine type I collagen |
- |
- |
- |
051 [1] 51 💬 |
866 |
Oral bovine type ii collagen |
- |
- |
- |
- |
046 [1] 46 💬 |
867 |
Oral ciprofloxacin plus inhaled colistin |
Ciprofloxacin |
[4] D00186 D00186, D02138 D02138, D02216 D02216, D07746 D07746 💬 |
- |
- |
299 [1] 299 💬 |
868 |
Oral corticosteroids |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
869 |
Oral corticosteroids (ocs) |
- |
- |
- |
- |
162 [1] 162 💬 |
870 |
Oral prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [2] 49, 145 💬 |
871 |
Orencia 250 mg polvo para concentrado para sol. para perfusión |
- |
- |
- |
- |
046 [1] 46 💬 |
872 |
Orencia 250mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
046 [1] 46 💬 |
873 |
Orkambi 100 mg/125 mg film-coated tablets |
- |
- |
- |
- |
299 [1] 299 💬 |
874 |
Orkambi 200 mg/125 mg film-coated tablets |
- |
- |
- |
- |
299 [1] 299 💬 |
875 |
Orkambi: contains lumacaftor and ivacaftor |
Ivacaftor |
[2] D09916 D09916, D10134 D10134 💬 |
CFTR [1] CFTR 💬 |
ABC transporters [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 [1] 299 💬 |
876 |
Other cox-2 inhibitor |
- |
- |
- |
- |
271 [1] 271 💬 |
877 |
Other cox-2 inhibitors |
- |
- |
- |
- |
271 [1] 271 💬 |
878 |
Other: 0.9% sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
065 [1] 65 💬 |
879 |
Other: 0.9ml sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
271 [1] 271 💬 |
880 |
Other: 60% oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
881 |
Other: abdominal compression |
- |
- |
- |
- |
017 [1] 17 💬 |
882 |
Other: ad libitum water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
883 |
Other: air - oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
884 |
Other: assessment of medication compliance |
- |
- |
- |
- |
098 [1] 98 💬 |
885 |
Other: blood collection for measurement of eculizumab peak concentrations |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [1] 62 💬 |
886 |
Other: blood sample and cotton skin swabs |
Cotton |
- |
- |
- |
162 [1] 162 💬 |
887 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
888 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
889 |
Other: cawthorne cooksey exercises |
- |
- |
- |
- |
013 [1] 13 💬 |
890 |
Other: coa-z |
- |
- |
- |
- |
120 [1] 120 💬 |
891 |
Other: coaching sessions |
- |
- |
- |
- |
049 [1] 49 💬 |
892 |
Other: coduse balance training and step square exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
893 |
Other: coffee |
- |
- |
- |
- |
096 [1] 96 💬 |
894 |
Other: cognitive training |
- |
- |
- |
- |
206 [1] 206 💬 |
895 |
Other: colchicine cessation |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
896 |
Other: collection of csf, blood, urine, saliva |
- |
- |
- |
- |
006 [1] 6 💬 |
897 |
Other: communicative effectiveness survey |
- |
- |
- |
- |
002 [1] 2 💬 |
898 |
Other: comparator: cpet cycle ergometer (gold standard) |
Gold |
- |
- |
- |
299 [1] 299 💬 |
899 |
Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
900 |
Other: concomitant medication |
- |
- |
- |
- |
049 [1] 49 💬 |
901 |
Other: continuation of dornase alfa (dnase) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
902 |
Other: continuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
903 |
Other: continue their usual therapy |
- |
- |
- |
- |
066 [1] 66 💬 |
904 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
905 |
Other: control diet |
- |
- |
- |
- |
096 [1] 96 💬 |
906 |
Other: control group |
- |
- |
- |
- |
002 [1] 2 💬 |
907 |
Other: control group(normal saline) |
- |
- |
- |
- |
097 [1] 97 💬 |
908 |
Other: control wound treatment |
- |
- |
- |
- |
036 [1] 36 💬 |
909 |
Other: controlled environment tests (series of tasks of everyday life) |
- |
- |
- |
- |
006 [1] 6 💬 |
910 |
Other: controls primary cervical dystonia (trihexyphenidyl) |
Trihexyphenidyl |
[2] D00787 D00787, D08638 D08638 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
911 |
Other: conventional balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
912 |
Other: conventional drugs |
- |
- |
- |
- |
097 [1] 97 💬 |
913 |
Other: conventional pca mode |
- |
- |
- |
- |
070 [1] 70 💬 |
914 |
Other: core stability |
- |
- |
- |
- |
013 [1] 13 💬 |
915 |
Other: corn starch |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
049 [1] 49 💬 |
916 |
Other: corticotropin releasing hormone (crh) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
917 |
Other: cough monitor |
Methamidophos |
- |
- |
- |
085 [1] 85 💬 |
918 |
Other: dead sea solar and water treatment |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
919 |
Other: dextrose water 5% |
Dextrose, unspecified form |
[1] D00001 D00001 💬 |
- |
- |
056 [1] 56 💬 |
920 |
Other: diary completion |
- |
- |
- |
- |
006 [1] 6 💬 |
921 |
Other: dyt 1 dystonia (healthy control) |
- |
- |
- |
- |
006 [1] 6 💬 |
922 |
Other: exercise followed cold water immersion |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
923 |
Other: group exercise: community setting |
- |
- |
- |
- |
070 [1] 70 💬 |
924 |
Other: harkány medicinal water |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
925 |
Other: healthy controls |
- |
- |
- |
- |
063 [1] 63 💬 |
926 |
Other: high resolution peripheral quantitative computed tomography (hrpqct) |
- |
- |
- |
- |
172 [1] 172 💬 |
927 |
Other: high water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
928 |
Other: histamine |
Histamine |
[1] D08040 D08040 💬 |
HRH1 [4] HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
929 |
Other: historical control |
- |
- |
- |
- |
002 [1] 2 💬 |
930 |
Other: human umbilical cord-derived mscs and cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
931 |
Other: hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
932 |
Other: hyperbaric oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
096 [1] 96 💬 |
933 |
Other: hyperbaric oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
097 [2] 97, 226 💬 |
934 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
[6] D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
935 |
Other: impact of biotherapy on postoperative morbidity in ulcerative colitis |
- |
- |
- |
- |
097 [1] 97 💬 |
936 |
Other: iv steroids combination alone |
- |
- |
- |
- |
041 [1] 41 💬 |
937 |
Other: leukapheresis- collection of stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
938 |
Other: losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
939 |
Other: low blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
940 |
Other: medication compliance phone call |
- |
- |
- |
- |
098 [1] 98 💬 |
941 |
Other: natural herbs of coconut, aloe vera, and pepperint |
Aloe Vera Leaf |
- |
- |
- |
053 [1] 53 💬 |
942 |
Other: no msdmds therapy (control) |
- |
- |
- |
- |
013 [1] 13 💬 |
943 |
Other: normal (control) diet |
- |
- |
- |
- |
240 [1] 240 💬 |
944 |
Other: nutrition counseling |
- |
- |
- |
- |
298 [1] 298 💬 |
945 |
Other: observational cohort |
- |
- |
- |
- |
006 [1] 6 💬 |
946 |
Other: observational control |
- |
- |
- |
- |
013 [1] 13 💬 |
947 |
Other: optional blood-oxygen-level dependent functionalmri |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [1] 6 💬 |
948 |
Other: oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
949 |
Other: oxygen (2liter/min) |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
950 |
Other: oxygen (4liter/min) |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
951 |
Other: oxygen - air |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
952 |
Other: oxygen supplementation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [1] 86 💬 |
953 |
Other: pittsburgh compound b [11c]-pib |
Pittsburgh Compound B |
- |
- |
- |
006 [1] 6 💬 |
954 |
Other: plasticity-based computerized cognitive remediation program |
- |
- |
- |
- |
013 [1] 13 💬 |
955 |
Other: potable water |
Water |
[1] D00001 D00001 💬 |
- |
- |
019 [1] 19 💬 |
956 |
Other: reaction time and postural control |
- |
- |
- |
- |
299 [1] 299 💬 |
957 |
Other: serum calcium concentrations results |
Calcium |
- |
- |
- |
235 [1] 235 💬 |
958 |
Other: sham abdominal compression |
- |
- |
- |
- |
017 [1] 17 💬 |
959 |
Other: sham comparator |
- |
- |
- |
- |
299 [1] 299 💬 |
960 |
Other: sham-procedure (dose cohort 1&2 only) |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
961 |
Other: sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
051 [1] 51 💬 |
962 |
Other: standard blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
963 |
Other: technetium [tc-99m] sulfur colloid and indium [in-111] dtpa |
Indium |
[1] D05422 D05422 💬 |
- |
- |
299 [1] 299 💬 |
964 |
Other: the patients' parents have to complete the vineland ii adaptive behavior scales scoring, the sleep disturbance scale for children (sdsc) and horne & ostberg circadian typology questionnaire |
- |
- |
- |
- |
149 [1] 149 💬 |
965 |
Other: ulcerative colitis diet |
- |
- |
- |
- |
097 [1] 97 💬 |
966 |
Other: untreated cohort |
- |
- |
- |
- |
085 [1] 85 💬 |
967 |
Other: voluntary cough test |
- |
- |
- |
- |
006 [1] 6 💬 |
968 |
Other: water |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
969 |
Other: water prescription |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
970 |
Over the counter dha/epa dietary supplementation |
- |
- |
- |
- |
301 [1] 301 💬 |
971 |
Over-encapsulated entacapone tablets |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
972 |
Overencapsulated prednisolone tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
973 |
Ovine corticotropin-releasing hormone (ocrh) |
Corticorelin |
[2] D00146 D00146, D03905 D03905 💬 |
CRHR1 [3] CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
974 |
Oxycodone by patient-controlled analgesia (pca) |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
975 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
976 |
Oxygen 40 % |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
977 |
Oxygen supplementation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [1] 86 💬 |
978 |
Oxygen, liquid |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [2] 86, 88 💬 |
979 |
Oxytocin (oxt) continuous |
Oxytocin |
[1] D00089 D00089 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
980 |
Pancrecarb® (pancrelipase) |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
299 [1] 299 💬 |
981 |
Pancrelipase |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
982 |
Pancrelipase amylase |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
299 [1] 299 💬 |
983 |
Pancrelipase delayed release |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
299 [1] 299 💬 |
984 |
Pancrelipase delayed release capsule |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
985 |
Pancrelipase microtablets |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
299 [1] 299 💬 |
986 |
Pancrelipase with bicarbonate |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
299 [1] 299 💬 |
987 |
Pancrelipase/pancreas powder |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
988 |
Paroxetine & prednisolone |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
989 |
Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
990 |
Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp |
Paroxetine |
[12] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02260 D02260, D02362 D02362, D03301 D03301, D05374 D05374, D05375 D05375 💬 |
NR3C1 [2] NR3C1, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
991 |
Part 1, jm-010 component group a |
- |
- |
- |
- |
006 [1] 6 💬 |
992 |
Part 1, jm-010 component group b |
- |
- |
- |
- |
006 [1] 6 💬 |
993 |
Part 1, jm-010 component group c |
- |
- |
- |
- |
006 [1] 6 💬 |
994 |
Part 2, jm-010 combination group a |
- |
- |
- |
- |
006 [1] 6 💬 |
995 |
Part 2, jm-010 combination group b |
- |
- |
- |
- |
006 [1] 6 💬 |
996 |
Part 2, jm-010 component group c |
- |
- |
- |
- |
006 [1] 6 💬 |
997 |
Pct (purecell technologies complex) |
- |
- |
- |
- |
097 [1] 97 💬 |
998 |
Peg-liposomal prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
999 |
Pentasa compact 2g, granulate with prolonged release |
- |
- |
- |
- |
097 [1] 97 💬 |
1000 |
Pentasa compact 4g, granulate with prolonged release |
- |
- |
- |
- |
097 [1] 97 💬 |
1001 |
Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping |
- |
- |
- |
- |
113 [1] 113 💬 |
1002 |
Perfluorinated gas/oxygen mixture |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
1003 |
Ph-combination therapy |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
1004 |
Phase 1: conventiaonal dmard |
- |
- |
- |
- |
046 [1] 46 💬 |
1005 |
Physiological serum (sodium chloride) |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
193 [1] 193 💬 |
1006 |
Piperacillin-tazobactam combination product |
Piperacillin |
[4] D00466 D00466, D00660 D00660, D02251 D02251, D08380 D08380 💬 |
- |
- |
299 [1] 299 💬 |
1007 |
Pittsburgh compound b |
Pittsburgh Compound B |
- |
- |
- |
006 [2] 6 , 127 💬 |
1008 |
Pittsburgh compound b (c-11 pib) |
Pittsburgh Compound B |
- |
- |
- |
127 [1] 127 💬 |
1009 |
Pl 12185/0002 & pl 12185/0005(water for injection) |
Water |
[1] D00001 D00001 💬 |
- |
- |
057 [1] 57 💬 |
1010 |
Placental mesenchymal stem cells seeded on a commercially available dural graft extracellular matrix |
Placental Mesenchymal Stem Cells |
- |
- |
- |
118 [1] 118 💬 |
1011 |
Plaquenil - hydroxychloroquine 200mg film coated tablets |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
043 [3] 43, 44, 45 💬 |
1012 |
Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología prgf-system (bti) |
- |
- |
- |
- |
096 [1] 96 💬 |
1013 |
Plasma-derived fviii/vwf concentrate |
- |
- |
- |
- |
288 [1] 288 💬 |
1014 |
Plerixafor for conditioning before hsct. |
Plerixafor |
[1] D08971 D08971 💬 |
CXCR4 [1] CXCR4 💬 |
Axon guidance [12] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor |
065 [1] 65 💬 |
1015 |
Pneumococcal conjugate vaccine |
- |
- |
- |
- |
046 [1] 46 💬 |
1016 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 [1] 46 💬 |
1017 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
1018 |
Prednisolone & dipyridamole |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
1019 |
Prednisolone + mabthera |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
061 [1] 61 💬 |
1020 |
Prednisolone 1mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
1021 |
Prednisolone 2,5 mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
1022 |
Prednisolone 20 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1023 |
Prednisolone 40 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1024 |
Prednisolone 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 51 💬 |
1025 |
Prednisolone 5 mg jenapharm |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
1026 |
Prednisolone 5 mg tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
1027 |
Prednisolone 5mg gastro-resistant tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
1028 |
Prednisolone 5mg tablet |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
1029 |
Prednisolone acetate |
Acetate |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
1030 |
Prednisolone and chlorambucil |
Chlorambucil |
[9] D00266 D00266, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
1031 |
Prednisolone and mycophenolate mofetil |
Mycophenolate mofetil |
[12] D00472 D00472, D00752 D00752, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [3] IMPDH1, IMPDH2, NR3C1 💬 |
Drug metabolism - other enzymes [4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism |
222 [1] 222 💬 |
1032 |
Prednisolone and taper |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
1033 |
Prednisolone labesfal |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1034 |
Prednisolone sodium metasulphobenzoate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
1035 |
Prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
1036 |
Prednisolone sodium succinate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
095 [1] 95 💬 |
1037 |
Prednisolone tablets b.p. 5mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
1038 |
Prednisolone tablets bp |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1039 |
Prednisolone tablets bp 1 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1040 |
Prednisolone tablets usp 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1041 |
Prednisolone-dipyridamole |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
1042 |
Prednisolone/prednisone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
1043 |
Prednisone + inhibace/cozaar |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
1044 |
Prednisone or prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
1045 |
Prednisone/prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
1046 |
Probiotic capsules containing lactobacillus rhamnosus gr-1 and l. reuteri rc-14 |
- |
- |
- |
- |
046 [1] 46 💬 |
1047 |
Procedure: 2 ml of whole blood sample will be collected on edta tube |
Edetic acid |
[8] D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 [1] 51 💬 |
1048 |
Procedure: 9% sodium chloride (nacl) iv |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
078 [1] 78 💬 |
1049 |
Procedure: assessment of therapy complications |
- |
- |
- |
- |
060 [1] 60 💬 |
1050 |
Procedure: biospecimen collection |
- |
- |
- |
- |
159 [1] 159 💬 |
1051 |
Procedure: blood collection for pk testing (15 mins before injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1052 |
Procedure: blood collection for pk testing (15 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1053 |
Procedure: blood collection for pk testing (18-20 hours post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1054 |
Procedure: blood collection for pk testing (180 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1055 |
Procedure: blood collection for pk testing (60 minutes post injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1056 |
Procedure: blood collection for pk testing (after injection) |
- |
- |
- |
- |
046 [1] 46 💬 |
1057 |
Procedure: blood sampling from umbilical cord |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
1058 |
Procedure: bone marrow or umbilical cord blood (ucg) stem cell transplantation |
- |
- |
- |
- |
036 [1] 36 💬 |
1059 |
Procedure: clobetasol propionate |
Clobetasol |
[2] D01272 D01272, D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
162 [1] 162 💬 |
1060 |
Procedure: colectomy |
- |
- |
- |
- |
097 [1] 97 💬 |
1061 |
Procedure: collagenase |
Collagenase clostridium histolyticum |
[1] D09596 D09596 💬 |
- |
- |
162 [1] 162 💬 |
1062 |
Procedure: colonoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
1063 |
Procedure: colorectal biopsies |
- |
- |
- |
- |
097 [1] 97 💬 |
1064 |
Procedure: computed tomography |
- |
- |
- |
- |
034 [5] 34, 40, 46, 49, 96 💬 |
1065 |
Procedure: continuous glucose monitoring system (cgms) |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
1066 |
Procedure: continuous mononuclear cell collection (cmnc) |
- |
- |
- |
- |
096 [1] 96 💬 |
1067 |
Procedure: contrast sensitivity measurement |
- |
- |
- |
- |
019 [1] 19 💬 |
1068 |
Procedure: control group |
- |
- |
- |
- |
034 [1] 34 💬 |
1069 |
Procedure: conventional surgery |
- |
- |
- |
- |
034 [1] 34 💬 |
1070 |
Procedure: cord blood |
- |
- |
- |
- |
060 [1] 60 💬 |
1071 |
Procedure: cord blood infusion |
- |
- |
- |
- |
060 [1] 60 💬 |
1072 |
Procedure: coronary flow reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
1073 |
Procedure: drug coated balloon (dcb) |
- |
- |
- |
- |
040 [1] 40 💬 |
1074 |
Procedure: dynamic contrast-enhanced magnetic resonance imaging |
- |
- |
- |
- |
013 [1] 13 💬 |
1075 |
Procedure: hydrocortisone withdrawal |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
1076 |
Procedure: hyperbaric oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
097 [1] 97 💬 |
1077 |
Procedure: hyperbaric oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
090 [1] 90 💬 |
1078 |
Procedure: left ventricular contractile reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
1079 |
Procedure: long term oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
088 [1] 88 💬 |
1080 |
Procedure: management of therapy complications |
- |
- |
- |
- |
028 [2] 28, 60 💬 |
1081 |
Procedure: mri imaging with intravenous contrast with gadoterate meglumine |
Gadoteric acid |
[2] D01796 D01796, D08007 D08007 💬 |
- |
- |
053 [1] 53 💬 |
1082 |
Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit) |
- |
- |
- |
- |
049 [1] 49 💬 |
1083 |
Procedure: oxygen flow at the optic nerve head measurement |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
019 [1] 19 💬 |
1084 |
Procedure: single photon emission computed tomography |
- |
- |
- |
- |
034 [1] 34 💬 |
1085 |
Procedure: sputum collection |
- |
- |
- |
- |
299 [1] 299 💬 |
1086 |
Procedure: stem cell collection |
- |
- |
- |
- |
028 [1] 28 💬 |
1087 |
Procedure: stem cell or umbilical cord blood transplantation |
- |
- |
- |
- |
326 [1] 326 💬 |
1088 |
Procedure: supplemental oxygen via a mask |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
088 [1] 88 💬 |
1089 |
Procedure: umbilical cord blood therapy |
Umbilical Cord Blood Hematopoietic Stem Cells |
- |
- |
- |
002 [2] 2 , 6 💬 |
1090 |
Procedure: umbilical cord blood transplantation |
- |
- |
- |
- |
060 [5] 60, 65, 284, 285, 326 💬 |
1091 |
Procedure: urinary collect |
- |
- |
- |
- |
299 [1] 299 💬 |
1092 |
Procedure: urine collection |
- |
- |
- |
- |
019 [1] 19 💬 |
1093 |
Procedure: warm compress prior to injection of glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
1094 |
Procedure: water exercises |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
1095 |
Products containing aminosalicylate |
- |
- |
- |
- |
097 [1] 97 💬 |
1096 |
Products containing azathioprine or 6-mercaptopurine |
Azathioprine |
[4] D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
097 [1] 97 💬 |
1097 |
Prothrombin complex concentrate |
Factor IX Complex (Human) |
- |
- |
- |
288 [1] 288 💬 |
1098 |
Ps188 (company code) |
- |
- |
- |
- |
113 [1] 113 💬 |
1099 |
Pseudoephedrine + 480 ml water |
Pseudoephedrine |
[5] D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
1100 |
Pseudoephedrine + 50 ml water |
Pseudoephedrine |
[5] D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
1101 |
Ptc0161480, ptc124 compound 1a, rps2505, ptc-c124, 291844 |
- |
- |
- |
- |
113 [1] 113 💬 |
1102 |
Pyridoxine plus prednisolone |
Prednisolone |
[10] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02179 D02179, D03301 D03301, D08454 D08454 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
145 [1] 145 💬 |
1103 |
Radiation: computed tomography lung subtraction iodine mapping |
Iodine |
[1] D00108 D00108 💬 |
- |
- |
088 [1] 88 💬 |
1104 |
Radiation: computerized tomography scan |
- |
- |
- |
- |
098 [1] 98 💬 |
1105 |
Radiation: cone beam computed tomography (cbct) |
Tricyclazole |
- |
- |
- |
051 [1] 51 💬 |
1106 |
Radiation: single photon emission computed tomography scans |
- |
- |
- |
- |
098 [1] 98 💬 |
1107 |
Rapamune - 1 mg 100 compresse rivestite in blister uso orale |
- |
- |
- |
- |
002 [1] 2 💬 |
1108 |
Rapamycin-calcitriol combination |
Calcitriol |
[2] D00129 D00129, D00753 D00753 💬 |
MTOR [2] MTOR, VDR 💬 |
AMPK signaling pathway [54] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway |
158 [1] 158 💬 |
1109 |
Raxone - 150 mg- compresse rivestite con film- uso orale- flacone (hdpe)- 180 compresse |
- |
- |
- |
- |
113 [1] 113 💬 |
1110 |
Recombinanat dna-derived human growth hormone produced in e.coli |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
1111 |
Recombinant aav vector serotype 2 containing the human wild type mitochondrial nd4 gene |
- |
- |
- |
- |
302 [1] 302 💬 |
1112 |
Recombinant adeno-associated viral vector serotype 2.7m8 containing the chrimsonr-tdtomato gene |
- |
- |
- |
- |
090 [1] 90 💬 |
1113 |
Recombinant adeno-associated viral vector, serotype 2 (raav2/2) containing the human wild-type mitochondrial nadh dehydrogenase 4 gene (nd4) |
NADH |
- |
- |
- |
302 [1] 302 💬 |
1114 |
Recombinant coagulation fviii fc – von willebrand factor – xten fusion protein |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
1115 |
Recombinant coagulation fviii fc – vonwillebrand factor – xten fusion protein |
- |
- |
- |
- |
288 [1] 288 💬 |
1116 |
Recombinant dna-derived human growth hormone produced in e.coli |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
1117 |
Recombinant granulocyte - colony stimulating factor |
- |
- |
- |
- |
039 [1] 39 💬 |
1118 |
Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-man6 glycan |
Phosphate ion |
- |
- |
- |
256 [1] 256 💬 |
1119 |
Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
1120 |
Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
[1] D11744 D11744 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
1121 |
Recombinant human angiotensin-converting enzyme 2 |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
1122 |
Recombinant human angiotensin-converting enzyme 2 (ace2), apn01 |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
1123 |
Recombinant human apolipoprotein a-i/phospholipids complex |
Omega-3 fatty acids |
- |
- |
- |
079 [1] 79 💬 |
1124 |
Recombinant human coagulation factor viii fc - von willebrand factor - xten fusion protein |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
1125 |
Recombinant porcine coagulation factor viii (b domain deleted) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
1126 |
Recombinant porcine coagulation factor viii (b-domain deleted) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
1127 |
Reduced intensity conditioning |
- |
- |
- |
- |
019 [2] 19, 65 💬 |
1128 |
Reduced intensity conditioning (ric) |
- |
- |
- |
- |
065 [1] 65 💬 |
1129 |
Reduced intensity transplant conditioning |
- |
- |
- |
- |
036 [1] 36 💬 |
1130 |
Regimen selection phase group 1 (completed) |
- |
- |
- |
- |
113 [1] 113 💬 |
1131 |
Remicade 100 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
1132 |
Remicade 100 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1133 |
Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
1134 |
Repository corticotropin injection |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [5] 2 , 13, 46, 84, 222 💬 |
1135 |
Repository corticotropin injection -treatment extension |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 [1] 84 💬 |
1136 |
Revatio 20 mg film coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
1137 |
Revatio 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
1138 |
Revatio 20 mg, comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
1139 |
Revatio ® 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
1140 |
Revolade 25 mg film-coated tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
1141 |
Revolade 50 mg film-coated tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
1142 |
Rhtpo in combination with rituximab |
Recombinant Human Thrombopoietin |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
1143 |
Ribavirin |
Ribavirin |
[1] D00423 D00423 💬 |
- |
- |
002 [2] 2 , 96 💬 |
1144 |
Rifaximin delayed release 400 mg film coated tablet |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
096 [1] 96 💬 |
1145 |
Rilutek 50 mg film-coated tablets |
- |
- |
- |
- |
002 [1] 2 💬 |
1146 |
Rilutek 50 mg, film-coated tablets |
- |
- |
- |
- |
002 [1] 2 💬 |
1147 |
Riluzolo teva - 50 mg compresse rivestite con film 90 compresse in blister al/pvc |
- |
- |
- |
- |
114 [1] 114 💬 |
1148 |
Riociguat coated tablet 0.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
1149 |
Riociguat coated tablet 1.0 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
1150 |
Riociguat coated tablet 1.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
1151 |
Riociguat coated tablet 2.0 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
1152 |
Riociguat coated tablet 2.5 m |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
1153 |
Riociguat coated tablet 2.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
1154 |
Risperidone |
Risperidone |
[1] D00426 D00426 💬 |
DRD2 [2] DRD2, HTR2A 💬 |
Alcoholism [11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
008 [5] 8 , 156, 179, 187, 206 💬 |
1155 |
Rituximab combined with omalizumab |
Omalizumab |
[2] D02994 D02994, D05251 D05251 💬 |
FCER1A [2] FCER1A, MS4A1 💬 |
Asthma [5] Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
162 [1] 162 💬 |
1156 |
Rituximab-eu+ rituximab-pfizer x 2 courses |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
1157 |
Rituximab-pfizer (pf-05280586) x 3 courses |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
1158 |
Rituximab-us + rituximab-pfizer x 2 courses |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
1159 |
Ro4964913/f07-01 (commercial) |
- |
- |
- |
- |
013 [1] 13 💬 |
1160 |
Roactemra 20 mg/ml concentrado para solución para perfusión |
- |
- |
- |
- |
046 [1] 46 💬 |
1161 |
Roactemra 20 mg/ml concentrate for solution for infusion |
- |
- |
- |
- |
046 [1] 46 💬 |
1162 |
Roactemra 20 mg/ml concentrate for solution for infusion. |
- |
- |
- |
- |
046 [1] 46 💬 |
1163 |
Roactemra 20 mg/ml, concentrado para solución para perfusión |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
1164 |
Roactemra®ev product code: prd82321 |
- |
- |
- |
- |
046 [1] 46 💬 |
1165 |
Ropinirole controlled-release (requip cr) for rls |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1166 |
Rva576 (coversin) |
Nomacopan |
[1] D11473 D11473 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [2] 62, 109 💬 |
1167 |
S-warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
013 [1] 13 💬 |
1168 |
S95011 concentrate for solution for infusion |
- |
- |
- |
- |
053 [1] 53 💬 |
1169 |
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) |
Amitriptyline |
[7] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D02691 D02691, D07448 D07448, D08623 D08623 💬 |
GHR [4] GHR, OPRM1, SLC6A2, SLC6A4 💬 |
Cytokine-cytokine receptor interaction [9] Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
1170 |
Secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
013 [7] 13, 37, 41, 46, 160, 269, 271 💬 |
1171 |
Secukinumab (150 mg) |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
1172 |
Secukinumab (75 mg) |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
1173 |
Secukinumab (ain457) |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
046 [1] 46 💬 |
1174 |
Secukinumab (ain457) 150 mg s.c. |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
1175 |
Secukinumab 150 mg (2 injections per dose |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
269 [1] 269 💬 |
1176 |
Secukinumab 150 mg provided in 1.0 ml pre-filled syringes (pfss) for sc injection. |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
1177 |
Secukinumab 150 mg/1 ml solution for injection |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
037 [2] 37, 271 💬 |
1178 |
Secukinumab 150 milligram [cosentyx] |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
1179 |
Secukinumab 150mg |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
037 [1] 37 💬 |
1180 |
Secukinumab 300 mg, s.c. |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
041 [1] 41 💬 |
1181 |
Secukinumab 300mg |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
037 [1] 37 💬 |
1182 |
Secukinumab 75 mg/0.5 ml solution for injection |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
1183 |
Semi continuous intra-oral administration of ld/cd |
- |
- |
- |
- |
006 [1] 6 💬 |
1184 |
Serum containing avonex |
- |
- |
- |
- |
013 [1] 13 💬 |
1185 |
Sildenafil and losartan |
Losartan |
[4] D00357 D00357, D02229 D02229, D08146 D08146, D08514 D08514 💬 |
AGTR1 [2] AGTR1, PDE5A 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
1186 |
Simvastatin 40 mg film-coated tablets |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1187 |
Simvastatina sandoz 40 mg comprimidos recubiertos con película efg |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1188 |
Sin lv mediated ex vivo transduced autologous fibroblasts expressing codon-optimised col7a1 |
- |
- |
- |
- |
036 [1] 36 💬 |
1189 |
Sin rv-mediated col7a1 corrected autologous skin equivalent |
- |
- |
- |
- |
036 [1] 36 💬 |
1190 |
Sinemet (comparator) |
- |
- |
- |
- |
006 [1] 6 💬 |
1191 |
Sinemet 100 mg + 25 mg compresse |
- |
- |
- |
- |
006 [1] 6 💬 |
1192 |
Sinemet® controlled release (carbidopa/levodopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1193 |
Sinvastatina sandoz 40 mg comprimidos revestidos por película |
- |
- |
- |
- |
013 [1] 13 💬 |
1194 |
Site specific standard of care comparison |
- |
- |
- |
- |
038 [2] 38, 39 💬 |
1195 |
Sivatin 40 mg film-coated tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
1196 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
1197 |
Sodium chloride (7%) |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
299 [1] 299 💬 |
1198 |
Sodium chloride 0,9% |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
299 [1] 299 💬 |
1199 |
Sodium chloride 0.9% |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
014 [1] 14 💬 |
1200 |
Sodium chloride 6% |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
299 [1] 299 💬 |
1201 |
Sodium chloride 7% |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
299 [1] 299 💬 |
1202 |
Sodium chloride ph. eur. |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
299 [1] 299 💬 |
1203 |
Sodium chloride solution |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
011 [3] 11, 13, 228 💬 |
1204 |
Sodium chloride solution 0.9% |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
060 [3] 60, 288, 299 💬 |
1205 |
Sodium chloride solvent |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
228 [1] 228 💬 |
1206 |
Sodium pyruvate in 0.9% sodium chloride solution |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
299 [1] 299 💬 |
1207 |
Soliris - 300 mg concentrato per soluzione per infusione - uso endovenoso 1 flaconcino (vetro) 30 ml (10 mg/ml) |
- |
- |
- |
- |
109 [1] 109 💬 |
1208 |
Soliris 300 mg concentrado para solución para perfusión |
- |
- |
- |
- |
109 [1] 109 💬 |
1209 |
Solu-cortef |
- |
- |
- |
- |
006 [3] 6 , 81, 83 💬 |
1210 |
Solu-cortef (hydrocortisone) |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
1211 |
Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial' |
- |
- |
- |
- |
006 [1] 6 💬 |
1212 |
Soluble prednisolone tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
145 [1] 145 💬 |
1213 |
Solucion de cloruro de sodio sodium chloride solution |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
228 [1] 228 💬 |
1214 |
Solvente cloruro de sodio sodium chloride solvent |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
228 [1] 228 💬 |
1215 |
Somatropin (inn) recombinant dna orgin, escherichia coli |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
1216 |
Sorbitol |
Sorbitol |
[1] D00096 D00096 💬 |
- |
- |
006 [2] 6 , 10 💬 |
1217 |
Spironolactone and conivaptan |
Conivaptan |
[3] D00443 D00443, D01236 D01236, D07748 D07748 💬 |
AVPR1A [3] AVPR1A, AVPR2, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [6] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
1218 |
Spironolactone captopril carvedilol |
Captopril |
[4] D00251 D00251, D00255 D00255, D00443 D00443, D03415 D03415 💬 |
ACE [7] ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 |
AMPK signaling pathway [18] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
1219 |
Ss-adrenergic cocktail |
- |
- |
- |
- |
299 [1] 299 💬 |
1220 |
Stalevo (levodopa/ carbidopa/ entacapone) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1221 |
Stalevo (levodopa/carbidopa/entacapone) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1222 |
Standard analgesia use [oxygen] |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
070 [1] 70 💬 |
1223 |
Standard continuous antiretroviral therapy |
- |
- |
- |
- |
265 [1] 265 💬 |
1224 |
Standard gadolinium contrast |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
1225 |
Standard treatment with a conventional drug |
- |
- |
- |
- |
013 [1] 13 💬 |
1226 |
Stelara 130 mg concentrate for solution for infusion |
- |
- |
- |
- |
096 [1] 96 💬 |
1227 |
Sterile water |
Water |
[1] D00001 D00001 💬 |
- |
- |
078 [1] 78 💬 |
1228 |
Sterile water for injection |
Water |
[1] D00001 D00001 💬 |
- |
- |
078 [1] 78 💬 |
1229 |
Sterilised water for injections |
Water |
[1] D00001 D00001 💬 |
- |
- |
078 [1] 78 💬 |
1230 |
Subcutaneous hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
1231 |
Subcutaneous hydrocortisone 10mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
1232 |
Subretinal injection of umbilical cord blood platelet-rich plasma (cb-prp) |
- |
- |
- |
- |
090 [1] 90 💬 |
1233 |
Sucrose |
Sucrose |
[1] D00025 D00025 💬 |
- |
- |
062 [3] 62, 96, 97 💬 |
1234 |
Sulfur colloid |
- |
- |
- |
- |
299 [1] 299 💬 |
1235 |
Sulphasalazine + hydroxychloroquine or prednisolone |
Hydroxychloroquine |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1236 |
Sulphsalazine, pentasa, asacol, colazide, depentum |
- |
- |
- |
- |
097 [1] 97 💬 |
1237 |
Suspension containing 250 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1238 |
Suspension containing 250 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1239 |
Suspension containing 2500 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1240 |
Suspension containing 2500 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1241 |
Suspension containing 7500 embryonated viable trichuris suis ova/15ml |
- |
- |
- |
- |
097 [1] 97 💬 |
1242 |
Suspension containing 7500 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 [1] 96 💬 |
1243 |
Symkevi 100mg/150mg film-coated tablets |
- |
- |
- |
- |
299 [1] 299 💬 |
1244 |
Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin) |
Aldosterone |
[3] D00150 D00150, D02014 D02014, D10528 D10528 💬 |
AGTR1 [3] AGTR1, AGTR2, NR3C2 💬 |
AGE-RAGE signaling pathway in diabetic complications [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
1245 |
T-peptide-crm197 conjugate |
- |
- |
- |
- |
011 [1] 11 💬 |
1246 |
Tachipirina - 1000 mg compresse 8 compresse |
- |
- |
- |
- |
014 [1] 14 💬 |
1247 |
Tachipirina - 500 mg compresse20 compresse |
- |
- |
- |
- |
013 [2] 13, 53 💬 |
1248 |
Tacrolimus combined with prednisone |
Prednisone |
[3] D00107 D00107, D00473 D00473, D08556 D08556 💬 |
NR3C1 [6] NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
1249 |
Tadalafil 20 mg film-coated tablets |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
1250 |
Tadalafil and ambrisentan upfront combination therapy |
Ambrisentan |
[2] D02008 D02008, D07077 D07077 💬 |
EDNRA [2] EDNRA, PDE5A 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
1251 |
Tafamidis meglumine 20 mg soft gelatin capsules |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
1252 |
Tafamidis meglumine 20mg soft gelatin capsule (clinical trial image) |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
1253 |
Tafamidis meglumine 20mg soft gelatin capsule (commerical image) |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
1254 |
Tat4 gel concentration a |
- |
- |
- |
- |
265 [1] 265 💬 |
1255 |
Tat4 gel concentration b |
- |
- |
- |
- |
265 [1] 265 💬 |
1256 |
Technetium sulfur colloid |
- |
- |
- |
- |
299 [1] 299 💬 |
1257 |
Teriparatide [rdna origin] contains recombinant human parathyroid hormone (1-34) |
Parathyroid hormone |
[2] D05364 D05364, D06078 D06078 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 [1] 70 💬 |
1258 |
Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker |
Polyethylene glycol |
[2] D03370 D03370, D06078 D06078 💬 |
PTH1R [1] PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
1259 |
Tetanus toxoid (tt) containing vaccine (td, tdap) |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [1] 13 💬 |
1260 |
Tetracosactide |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
083 [4] 83, 113, 145, 222 💬 |
1261 |
Tetracosactide acetate |
Acetate |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
083 [2] 83, 145 💬 |
1262 |
Tetracosactide hexaacetate |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
113 [1] 113 💬 |
1263 |
Tetracosactide hexacetaat |
Tetracosactide |
[1] D00284 D00284 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
222 [1] 222 💬 |
1264 |
The comprehensive treatment regimen of traditional chinese medicine |
- |
- |
- |
- |
222 [1] 222 💬 |
1265 |
The generic name is warfarin and many producers will be involved |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 [1] 49 💬 |
1266 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
1267 |
The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
1268 |
The yi-qi-qing-jie herbal compound |
- |
- |
- |
- |
066 [1] 66 💬 |
1269 |
Timolol alcon 0.5% collyre |
Timolol |
[3] D00378 D00378, D00603 D00603, D08600 D08600 💬 |
ADRB1 [2] ADRB1, ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
227 [1] 227 💬 |
1270 |
Tissue selective estrogen complex |
- |
- |
- |
- |
013 [1] 13 💬 |
1271 |
To be confirmed |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
1272 |
Tobi 300mg/ 5ml solución para inhalación con nebulizador |
- |
- |
- |
- |
299 [1] 299 💬 |
1273 |
Tocilizumab and iv steroids combination |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 [1] 41 💬 |
1274 |
Tofacitinib citrate (commercial image) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1275 |
Tofacitinib citrate (proposed commercial formulation - debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 97 💬 |
1276 |
Tofacitinib citrate (proposed commercial formulation debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1277 |
Tofacitinib citrate (proposed commercial formulation – debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 97 💬 |
1278 |
Tofacitinib citrate (proposed commercial formulation- debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [1] 46 💬 |
1279 |
Tofacitinib citrate (proposed commercialformulation - debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1280 |
Topical compound tripterygium |
Tripterygium wilfordii whole |
- |
- |
- |
046 [1] 46 💬 |
1281 |
Tp05 coating a |
- |
- |
- |
- |
097 [1] 97 💬 |
1282 |
Tp05 coating b |
- |
- |
- |
- |
097 [1] 97 💬 |
1283 |
Tp05 coating d |
- |
- |
- |
- |
097 [1] 97 💬 |
1284 |
Tp05 coating e |
- |
- |
- |
- |
097 [1] 97 💬 |
1285 |
Tp05 coating h |
- |
- |
- |
- |
097 [1] 97 💬 |
1286 |
Tracleer 62,5 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
1287 |
Traditional chinese medicinal mixture (composed of roucongrong and adjuvant) |
- |
- |
- |
- |
006 [1] 6 💬 |
1288 |
Tralokinumab cohort 1 |
Tralokinumab |
[1] D09979 D09979 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 [1] 85 💬 |
1289 |
Tralokinumab cohort 2 |
Tralokinumab |
[1] D09979 D09979 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 [1] 85 💬 |
1290 |
Tramadol |
Tramadol |
[2] D01355 D01355, D08623 D08623 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [5] 46, 70, 78, 226, 271 💬 |
1291 |
Tramadol /acetaminophen |
Acetaminophen |
[3] D00217 D00217, D01355 D01355, D08623 D08623 💬 |
OPRM1 [3] OPRM1, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 [1] 271 💬 |
1292 |
Tramadol hydrochloride + acetaminophen |
Acetaminophen |
[3] D00217 D00217, D01355 D01355, D08623 D08623 💬 |
OPRM1 [3] OPRM1, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
1293 |
Tramadol with ropivacaine |
Ropivacaine |
[4] D01355 D01355, D04048 D04048, D08490 D08490, D08623 D08623 💬 |
OPRM1 [6] OPRM1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [6] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction |
070 [1] 70 💬 |
1294 |
Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col17a1-encoding retroviral vector |
- |
- |
- |
- |
036 [1] 36 💬 |
1295 |
Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col7a1-encoding retroviral vector |
- |
- |
- |
- |
036 [1] 36 💬 |
1296 |
Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col7a1-encoding retroviral vector, obtained from secondary culture of ex vivo expanded autologous human keratinocytes. |
- |
- |
- |
- |
036 [1] 36 💬 |
1297 |
Transplant conditioning with mobilization and alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
065 [1] 65 💬 |
1298 |
Transplant conditioning with mobilization only |
- |
- |
- |
- |
065 [1] 65 💬 |
1299 |
Treatment with topical superpotent corticosteroid therapy |
- |
- |
- |
- |
162 [1] 162 💬 |
1300 |
Trexan+salazopyrin+oxiklorin+prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
1301 |
Trexan+salazopyrin+oxiklorin+prednisolone + infliximab |
Infliximab |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02598 D02598, D03301 D03301 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
1302 |
Triple combination therapy |
- |
- |
- |
- |
299 [1] 299 💬 |
1303 |
Triptolide-containing formulation |
Triptolide |
- |
- |
- |
067 [1] 67 💬 |
1304 |
Triterpene dry extract from birch cork |
- |
- |
- |
- |
036 [1] 36 💬 |
1305 |
Tysabri 300 mg concentrado para solución para perfusión |
- |
- |
- |
- |
013 [1] 13 💬 |
1306 |
Tysabri 300 mg concentrate for solution for infusion |
- |
- |
- |
- |
013 [1] 13 💬 |
1307 |
Ultrasound microbubble contrast agent |
- |
- |
- |
- |
096 [1] 96 💬 |
1308 |
Umbilical cord blood |
- |
- |
- |
- |
060 [1] 60 💬 |
1309 |
Umbilical cord blood after myeloablative conditioning |
- |
- |
- |
- |
060 [1] 60 💬 |
1310 |
Umbilical cord blood after reduced-intensity conditioning |
- |
- |
- |
- |
060 [1] 60 💬 |
1311 |
Umbilical cord blood transplantation |
- |
- |
- |
- |
060 [1] 60 💬 |
1312 |
Umbilical cord blood unit |
- |
- |
- |
- |
333 [1] 333 💬 |
1313 |
Umbilical cord derived mesenchymal stem cell (uc -msc) transplantation |
- |
- |
- |
- |
093 [2] 93, 296 💬 |
1314 |
Umbilical cord derived mesenchymal stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
1315 |
Umbilical cord mesenchymal stem cell |
- |
- |
- |
- |
113 [1] 113 💬 |
1316 |
Umbilical cord mesenchymal stem cell (uc-msc) |
- |
- |
- |
- |
090 [1] 90 💬 |
1317 |
Umbilical cord mesenchymal stem cells |
- |
- |
- |
- |
013 [5] 13, 46, 57, 97, 113 💬 |
1318 |
Umbilical cord-derived mesenchymal stem cells (uc-mscs) |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
046 [1] 46 💬 |
1319 |
Unrelated cord blood |
- |
- |
- |
- |
065 [1] 65 💬 |
1320 |
Unrelated umbilical cord blood transplant |
- |
- |
- |
- |
019 [1] 19 💬 |
1321 |
Upadacitinib - direct compression-yellow |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1322 |
Upadacitinib -direct compression-yellow |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1323 |
Urbason 40 mg comprimidos |
- |
- |
- |
- |
013 [1] 13 💬 |
1324 |
Ursodeoxycholic acid combination of immunosuppressive agents |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [2] 93, 95 💬 |
1325 |
Ursodeoxycholic acid combined with total glucosides of paeony |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
1326 |
Ursofalk® 500 mg film-coated tablets |
- |
- |
- |
- |
093 [1] 93 💬 |
1327 |
Us tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
1328 |
V1512 and entacapone |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
1329 |
Valproid acid plus corticosteroids |
- |
- |
- |
- |
026 [1] 26 💬 |
1330 |
Vastarel 20mg film coated tablets |
- |
- |
- |
- |
058 [1] 58 💬 |
1331 |
Vector viral adenoasociado de serotipo 9 que contiene el gen de la sulfamidasa humana |
- |
- |
- |
- |
019 [1] 19 💬 |
1332 |
Vehice control |
- |
- |
- |
- |
096 [1] 96 💬 |
1333 |
Vehicle control |
- |
- |
- |
- |
053 [1] 53 💬 |
1334 |
Verapamil |
Verapamil |
[2] D00619 D00619, D02356 D02356 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [3] 96, 140, 167 💬 |
1335 |
Verapamil sr |
Verapamil |
[2] D00619 D00619, D02356 D02356 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
1336 |
Vett lentiviral con gene abca4 |
- |
- |
- |
- |
301 [1] 301 💬 |
1337 |
Viokase 16 (pancrelipase) + nexium |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [1] 298 💬 |
1338 |
Volibris 10 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
1339 |
Volibris 5 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
1340 |
Von willebrand factor and coagulation factor viii in combination |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
1341 |
Von willebrand factor ristocetin cofactor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
1342 |
Vwd factor viii concentrate |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
1343 |
Vwf-containing products |
- |
- |
- |
- |
288 [1] 288 💬 |
1344 |
Vx-661 plus ivacaftor combination |
Ivacaftor |
[1] D09916 D09916 💬 |
CFTR [1] CFTR 💬 |
ABC transporters [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 [1] 299 💬 |
1345 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
1346 |
Warfarin 10 mg |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
096 [2] 96, 97 💬 |
1347 |
Warfarin sodium |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 [1] 49 💬 |
1348 |
Warfarin+ vitamin k |
Phylloquinone |
[4] D00148 D00148, D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
046 [1] 46 💬 |
1349 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
1350 |
Water for injection |
Water |
[1] D00001 D00001 💬 |
- |
- |
035 [1] 35 💬 |
1351 |
Water for injections |
Water |
[1] D00001 D00001 💬 |
- |
- |
299 [1] 299 💬 |
1352 |
Water for injections, ep |
Water |
[1] D00001 D00001 💬 |
- |
- |
299 [1] 299 💬 |
1353 |
White chocolate (0% cocoa) |
Cocoa |
- |
- |
- |
006 [1] 6 💬 |
1354 |
Xeljanz 5 mg film-coated tablets |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
1355 |
Xeljanz 5mg film-coated tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
1356 |
Xenon contrast agent |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
022 [1] 22 💬 |
1357 |
Xyzal - 20 compresse ri |
- |
- |
- |
- |
053 [1] 53 💬 |
1358 |
Yondelis 0,25 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
159 [1] 159 💬 |
1359 |
Yondelis 0.25 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
159 [1] 159 💬 |
1360 |
Yondelis 1 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
159 [1] 159 💬 |
1361 |
Yondelis 1 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
159 [1] 159 💬 |
1362 |
Z102 (prednisolone and dipyridamole). |
Dipyridamole |
[9] D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [3] NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
1363 |
Zinc and copper |
Copper |
- |
- |
- |
002 [1] 2 💬 |
1364 |
Zuglimet - 500 mg compresse rivestite con film 30 compresse in blister pvc/al |
- |
- |
- |
- |
067 [1] 67 💬 |